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Abstract 
The accurate transmission of a genome into future generations, otherwise known as 
genome integrity, is necessary for life. However, genomic changes due to error or damage are 
quite common, with an estimated 38,000 DNA base alterations within a cell at any given 
moment. Thus, genomic integrity depends on high fidelity repair of DNA damage caused by 
endogenous and exogenous sources. Every cell has machinery that is capable of repairing DNA 
lesions, and defects in genes encoding DNA repair machinery frequently result in debilitating 
developmental disorders, cancer, and/or death.  
There are seven main pathways for DNA repair that have been identified: base excision 
repair, mismatch repair, nucleotide excision repair, interstrand crosslink repair, single strand 
break repair, non-homologous end joining, and homologous recombination. Pathway utilization 
depends on both the type of damage and the stage of the cell cycle. Homologous recombination 
is an especially important pathway, as it is the sole high fidelity means of repairing double 
stranded DNA breaks, which are particularly deleterious. It is estimated that ~10 unrepaired 
double strand breaks are lethal to a cell. The mechanisms that control double strand break repair 
are incompletely understood, but histone variant H2AZ exchange at DNA damage sites is 
believed to be an early step in the process and may be regulated by core histone modifications.  
DOT1-like (DOT1L), the human ortholog of the yeast gene DOT1 (Disruptor of 
telomeric silencing-1), is a histone H3 (H3K79) methyltransferase and has been implicated in 
DNA repair. This volume describes the use of both biological and computer science-based 
approaches to examine the specific function of DOT1L in DNA repair. Cells from DOT1L 
knockout mice were found to exhibit marked genomic instability and defects in DNA repair. 
Further, loss of DOT1L and/or its methylation activity resulted in decreased H2AZ incorporation 
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at double strand breaks and increased amounts of single strand DNA, leading to a specific defect 
in homologous recombination repair activity. Instead, in the absence of either DOT1L or H3K79 
methyltransferase activity, the non-homologous end joining repair pathway was utilized, 
resulting in genomic instability. These findings identify a novel role for DOT1L and H3K79 
methylation in facilitating histone exchange at double strand break sites, generating a chromatin 
state that is permissive for homologous recombination repair. This discovery emphasizes the 
diverse roles of epigenetic modification in biological processes beyond transcriptional control. 
Moreover, the identification of DOT1L function in DNA repair provides new opportunities for 
design and implementation of molecular therapeutics strategies that target DNA repair pathways 
to treat diseases. 
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Chapter I: Introduction 
How Is Genome Stability Maintained? 
 
Genome stability is a cellular trait that ensures accurate propagation of DNA. In order for 
a cell to maintain genome stability, it must be able to repair DNA damage induced by 
environmental changes. DNA damage can be induced by a variety of phenomenon such as 
deamination, depurination, alkylation, replication induced nucleotide misincorporation, and 
reactive oxygen species that are generated from cellular metabolism (Table 1.1). (ref for the 
table?) 
 
Table 1.1: Summary of DNA lesion type, cause, and frequency. (CM) cellular metabolism, 
(DR) DNA replication, (MT) molecular therapy, (IR) ionizing radiation. The frequency 
represents the average DNA lesion per cell at any given time.  
 
It is estimated that a cell can have more than an average of 38,000 DNA base alterations 
at any one time caused by endogenous DNA damaging factors [1]. Nucleotide misincorporation 
due to DNA replication is estimated to be less than 10-5 in normal tissue, but the vast majority of 
these alterations are repaired by cellular DNA repair machinery [2]. However, in disease states 
such as cancer, nucleotide misincorportation can be high due to mutations in genes required for 
DNA repair [3]. Other drivers of DNA damage include ionizing and ultraviolet radiation. 
Exposure to environmental ionizing radiation from sources such as radon (Rn-222) varies by 
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geographical location, but can generate two double strand breaks and over 1000 single strand 
breaks per cell [4]. UV radiation from direct sunlight can generate up to 10,000 lesions per cell, 
depending on the level of exposure [4]. 
 Molecular therapies used to treat cancer can also cause DNA damage. Four broad groups 
of chemotherapies exist that induce DNA damage: alkylating agents, antimetabolites, 
topoisomerase inhibitors, and cytotoxic antibiotics. Alkylating agents such as mechlorethamine, 
N-Nitroso-N-methylurea, dacarbazine, and cisplatin introduce covalent bonds between DNA and 
the proteins that bind them. Antimetabolites inhibit DNA or RNA synthesis. Treatment with 
antimetabolites such as anti-folates or thiopurines can induce DNA damage through the 
misincorporation of bases. The use of topoisomerase inhibitors such as irinotecan etoposide, and 
novobiocin act to prevent the release of tension produced on DNA through replication and 
transcription. The tension on DNA induced by replication and transcription is enough to break 
DNA if it is not released by the action of topoisomerase. Cytotoxic antibiotics such as 
doxorubicin, and bleomycin introduce DNA damage through DNA intercalation and free radical 
generation that can cause double strand breaks.  
 Cells have evolved mechanisms to respond to environmental challenges that damage 
DNA through the evolution of specialized DNA repair pathways. Chemical alterations on DNA 
bases are replaced via base excision repair (BER) pathway, while the misincorporation of bases 
is corrected by mismatch repair (MMR) pathway. Environmental challenges that introduce 
pyrimidine and thymine dimers are repaired by nucleotide excision repair (NER) pathway. 
Interstrand crosslinks are repaired via the interstrand crosslink repair (ICLR) pathway, which 
shares components with other DNA repair pathways. The single strand break repair (SSBR) 
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pathway repairs single strand breaks, while double strand breaks are repaired via homologous 
recombination (HR) or non-homologous end joining (NHEJ) repair pathways.  
 The use of individual repair pathways not only depends on the type of damage, but also 






Table 1.2: Summary of DNA lesion type and the phase of the cell cycle of maximum 
activity. (BER) base excision repair, (MMR) mismatch repair, (NER) nucleotide excision repair, 
(ICLR) interstrand crosslink repair, (SSBR) single strand break repair, (NHEJ) nonhomologous 
end joining, (HR) homologous recombination. G1/S/G2/M are the phases of the cell cycle. 
  
 Components of BER pathway are most active in the G1 phase of the cell cycle, however 
the repair can take place in other cell cycle phases as well [5]. The MMR pathway has maximal 
activity during S phase [6]. NER repair is active throughout the cell cycle [7]. ICLR pathway is 
most active during S phase [8]. SSB repair is hypothesized to be active at all phases of the cell 
cycle [9]. HR repair is maximally active in the S phase , while and NHEJ repair is active during 
all phases of the cell cycle [10].  
 DNA repair is carried out by multitude of proteins that modify DNA and the proteins 
surrounding the break site. The classes of proteins involved include kinases, acetyltransferases, 
methyltransferases, glycosylases, ubiquitin ligases, DNA ligases, helicases, polymerases, 
topoisomerases, recombinase, demethylases, deacetylases, phosphatases, and chaperons. The 
 4 
spatial and temporal assembly of DNA repair factors must be tightly controlled in order to 
maintain genome stability.  
 The complexity of the various DNA repair pathways is built upon two simple processes: 
detecting the DNA damage lesion and recruiting factors to the site of DNA damage. In 
eukaryotic cells genomic DNA is bound by histones and these histones serve as a binding 
platform for various DNA repair factors. Histones bind together with DNA to form a 
nucleosome. The nucleosome is composed of an H2A-H2B tetramer and an H3-H4 tetramer and 
DNA is wrapped around the entire complex. The nucleosomes can protect DNA from sources of 
endogenous DNA damage by limiting the surface area of DNA exposed to genotoxic agents. The 
intervening sequence between nucleosomes is more vulnerable to for DNA damaging agents.  
 Histones have four major types of modifications that constitute the histone code: 
acetylation, phosphorylation, methylation, and ubiquitination. Components of DNA repair 
pathways read the histone code in order to initiate specific types of DNA repair. The continual 
presence of the histone code serves as a marker that instructs the DNA repair machinery on the 
type of repair the needs to take place at specific regions of the genome. 
 The following sections will outline details of the various DNA repair pathways. The 
response to DNA damage is as diverse as the types of genotoxic factors cells are exposed to. 
Furthermore, this review will present the idea that utilization of specific repair pathways is 
governed by the epigenetic state of chromatin that is present in the region damaged. We 
hypothesize that the epigenetic landscape primes regions of the genome for different types of 
DNA repair. This hypothesis has broad implications, in particular for the administration of 
molecular therapies for cancers that target epigenetic factors.  
Base excision repair 
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 The base excision repair pathway can repair chemical alterations on DNA bases. The 
initial sensing of DNA base alterations is performed by DNA glycosylases. There are 11 unique 
DNA glycosylases in humans, each responsible for detecting a different type of DNA base 
modification [11]. The mechanism by which these glycosylases can detect a modified DNA base 
in the genome is still unclear. However, the human 8-Oxoguanine glycosylase (OGG1) can 
actively scan the DNA in a bilateral fashion looking for abnormal bases [12](Figure 1.1A). When 
a glycosylase encounters a modified base, it is excised leaving an abasic site (Figure 1.1B). The 
abasic site is a target for the DNA-(apurinic or apyrimidinic site) lyase (APE1), which cleaves 5ʹ 
of the abasic site generating a gap in the DNA [13] (Figure 1.1C). The gap in the DNA can be 
short (a single base) or long (2-10 bases). Depending on the length of the gap and the type of 
glycosylase that initiated the repair, different proteins are used to fill in the missing nucleotides 
[14]. Short-patch base excision utilizes DNA polymerase β (Pol β), DNA ligase I/ III 
(LIG1/LIG3), and x-ray repair cross-complementing protein 1 (XRCC1) to fill the gap 
[15](Figure 1.1D). Long-patch base excision repair takes place in proliferating cells and utilizes 
components of the replication machinery: Proliferating cell nuclear antigen (PCNA), DNA 
Ligase 1 (LIG1), and DNA polymerase ∂/ε (Pol ∂/Pol ε)[16] (Figure 1.1E).  
 There is evidence indicating that chromatin remodeling is required for efficient base 
excision repair processes. Studies on OGG1 show that removal of histone 1 (H1) is required for 
repair of modified bases [17]. Base excision repair using DNA polymerase β requires an active 
Imitation-switch 1 (ISW1) and Imitation-switch 2 (ISW2) remolding complexes [18]. These 
studies suggest that the chromatin state can influence repair fidelity at site of DNA damage. It 
stands to reason that factors, which alter chromatin remolding, could modulate BER activity. An 
interesting approach would be to test molecular therapeutics that target epigenetic marks in  
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Figure 1.1: Base excision repair pathway. A. OGG1 scans DNA looking for modified bases. 
B. Upon recognition of a modified base OGG1 excises the base. C. APE1 is recruited to the 
abasic site and cleaves five prime of the abasic site. D. If the cleavage 1 base, then short patch 
repair is used. E. If the cleaves is over 2 bases long patch repair is used. F. DNA ligase seal the 
filled in strands to generate double stranded product. 
 
conjunction with methanesulfonate, a highly mutagenic compound, to see if, similar to 
Poly(ADP-ribose) polymerase 1 (PARP) inhibitors, they can enhance or restrict base excision 
repair.  
Mismatch repair  
 The mismatch repair pathway is activated by the misincorporation of bases. Base 
mismatch errors are the least encountered type of DNA lesion during normal physiological 
conditions. This is due to the high fidelity proof reading capability of DNA polymerases that 
keep the numbers of mismatched bases low, and the activity of the MMR machinery itself. 
Incorporation of an incorrect base by the replication machinery is estimated to be less than 10-5 
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per base, and the MMR machinery has a high correction rate for most types of mismatches 
encountered that escape the proofreading capacity of DNA polymerases [19].  
The MMR machinery also processes insertion and deletion loops (IDLs), which are a result of 
primer strand slippage during replication [20]. 
 The principal components of the MMR machinery are male-specific lethal 1 homolog 
(MSL1), methyl-directed mismatch repair (mutS) homolog 2 (MSH2), mutS homolog 3 (MSH3), 
mutS homolog 6 (MSH6), postmeiotic segregation increased-1 homolog 2 (PMS2), proliferating 
cell nuclear antigen (PCNA), replication factor C (RFC), DNA polymerase δ (Pol δ) and DNA 
ligase I (LIG1), replication protein A (RPA), and exonuclease-1 (EXO1). These factors associate 
together in various complexes that repair specific types of DNA mismatches. The heterodimers 
MSH2/MSH6 form a complex called MutSα and repair single base mismatches and 1-2 IDL base 
mismatches, MLH1/PMS2 form the MutLα complex that associates with MutSα during repair, 
while MSH2/MSH3 form a complex called MutSβ and primarily repair IDL of greater than 2 
bases, but how it functions is still currently unknown [21].  
 In humans, MutSα and MutLα recognize base mismatches by detecting the distortion in 
the backbone of DNA caused by the mismatched bases while scanning the DNA [22](Figure 
1.2A). Upon binding MutSα/MutLα undergo translocation in either direction until they encounter 
and displace RFC from PCNA [23](Figure 1.2B). The displacement of RFC triggers the 
recruitment of EXO1, which degrades in the 5′→3′ direction [24](Figure 1.2C). The ssDNA that 
is generated is coated by RPA [25](Figure 1.2C). It is hypothesized that EXO1, PCNA and  
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Figure 1.2: Mismatch repair pathway. A. MutSα/MutLα detect the mismatch and translocate 
to PCNA. B. MutSα/MutLα/PCNA recruit EXO1 which degrades the DNA in the 5′→3′ 
direction, while RPA coats the ssDNA. C. The degradation of the mismatched base cases 
MutSα/MutLα and EXO1 to dissociate from PNCA. D. PCNA recruits Pol δ to fill in the gap and 
(E.) LIG1 seals the strand producing (F.) a double stranded product. 
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MutSα/MutLα move together as a complex and once the mismatch is removed this leads to 
destabilization of the EXO1/MutSα/MutLα complex (Figure 1.2C) and recruitment of Pol δ and 
LIG1 to seal the gap [26] (Figure 1.2D/F/G).  
 The traversing of MMR complex raises the question of how MMR functions in the 
presence of nucleosomes. It was revealed that the binding of MSH2/MSH6 to DNA results in 
chromatin remodeling around the mismatched base [27]. The binding of MSH2/MSH6 results in 
nucleosome disassembly, and this effect is enhanced when a modified H3K4 acetylation mimic 
was used [27]. This is intriguing because it suggests that histone modifications can modulate 
MMR. It has been demonstrated that cells lacking H3K36 tri-methylation have an identical 
mutational pattern to cells lacking a functional MMR pathway [28]. With this in mind, it would 
be interesting to perform a genome-wide assessment to test for a correlation between H3K36 
methylation and MMR hot spots.  
 
Nucleotide excision repair 
 
 Nucleotide excision repair can fix a wide variety of DNA lesions such as pyrimidine 
dimers and thymine dimers, cyclopurines, and intrastrand crosslinks that are introduced by UV 
radiation. There are two sub-pathways of NER: global genome nucleotide excision repair 
(ggNER) and transcriptional coupled nucleotide excision repair (tcNER). ggNER scans the entire 
genome looking for strand abnormalities, while tcNER is activated by template strand lesions 
that stall RNA polymerase II. 
 The main damage sensor for ggNER is the xeroderma pigmentosum C (XPC)/radiation 
sensitive 23 B (RAD23B)/centrin 2 (CETN2) complex, which actively searches DNA for 
mutations [29]. DNA damage caused by UV radiation decreases the affinity of  
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Figure 1.3: Nucleotide excision repair pathway. A. UV radiation introduces a DNA lesion. B. 
During ggNER, XPC/RAD23B/CETN2 and UV-DDB detect and bind to the lesion. C. In 
tcNER, CSA/CSB recruit UPS7/UVSSA to stalled RNA polymerase II and cause it to (E.) back 
track away from the lesion. D. During ggNER UV-DDB causes the dissociation of RAD23B 
from XPC/CETN2. F. ERCC2 is recruited to the lesion and unwinds the DNA allowing 
ERCC4/ERCC1 access to the 5ʹ  end of the lesion and ERCC5 access to the 3ʹ end. 
ERCC4/ERCC1 and ERCC5 cut the DNA excising the damaged portion. G. PCNA and one of 
three DNA polymerases (Pol δ, Pol ε, Pol κ) are recruited to the site to fill in the gap. H. DNA 
Ligase I seals the strand (I.) generating a dsDNA product.  
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XPC/RAD23B/CENT2 complex, allowing the UV-DDB complex composed of ubiquitin factors 
damage specific DNA binding protein 1 (DDB1), cullin 4A (CUL4A), ring-box 1 (RBX1), and 
DNA binding protein 1 (DDB2) to bind to the DNA [30](Figure 1.3B). The binding of UV-DDB 
causes RAD23B to dissociate from the UV-DDB complex, and initiates the recruitment of the 
NER repair machinery (Figure 1.3D).  
 During tcNER, the damage is detected indirectly through RNA polymerase II stalling. 
Stalling of RNA polymerase leads to the recruitment of the Cockayne syndrome WD repeat 
protein (CSA, ERCC8) and Cockayne syndrome protein B (CSB, ERCC6) [31]. When CSA and 
CSB bind the RNA polymerase II, this results in the recruitment of a complex of proteins (UV-
stimulated scaffold protein A (UVSSA), ubiquitin-specific-processing protease 7 (USP7) (Figure 
1.3C) and causes RNA polymerase II to back track [29, 32](Figure 1.3E).  
 At this point, the tcNER and ggNER pathways converge and both tcNER and ggNER 
complex can recruit XPA-binding protein 2 (XAB2), excision repair cross-complementing 2 
(ERCC2) and the excision repair cross-complementing 5 (ERCC5) endonuclease [29](Figure 
1.3F). The helicase activity of ERCC2 unwinds the DNA around the lesion, allowing the 
excision repair cross-complementing 4 (ERCC4)/excision repair cross-complementing 1 
(ERCC1) complex to cut the DNA 5ʹ of the lesion and ERCC5 to a cut 3ʹ of the lesion, and thus 
excise the damaged section of DNA [29](Figure 1.3F). Finally, PCNA, and one of three 
polymerases, Pol δ, DNA polymerase ε (Pol ε), DNA polymerase (Pol κ) and LIG1 are recruited 
to fill in and seal the gap (Figure 1.3G,H).  
 Chromatin remolding is required for both ggNER and tcNER to take place. The 
Switch/Sucrose non-fermentable (SWI/SNF) chromosome remodeling complex and INO80 
complex facilitate NER by recruiting XPC and XPA to sites of damage [33, 34]. Interestingly it 
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has been reported that disruptor of telomeric silencing 1-Like (DOT1L) functions in NER [35]. 
However, the authors attribute the effects of DOT1L on NER to transcriptional regulation rather 
than direct effects. Results presented in Chapter V encourage a revisit to the understanding of the 
role of DOT1L in NER. We show that DOT1L mutants have profound defects in histone 
remodeling around sites of DNA damage (Chapter II/IV). Specifically, we observe strong defects 
in histone 2A family member Z (H2AZ) incorporation following DNA damage induction in 
DOT1L deficient cells. It is of note that the yeast homologue of mammalian H2AZ, histone 2A 
Z1 (Htz1), is a positive regulator of NER and its incorporation into nucleosomes facilitates 
efficient NER. It would be interesting to test if the role of DOT1L in NER is a result of defects in 
H2AZ incorporation at sites of DNA damage, as has been observed for double strand break 
repair (Chapter II/V).  
Interstrand Crosslink Repair 
 
 Interstrand crosslinks of DNA are particularly toxic to cells because the separation of 
DNA is prevented, thereby inhibiting a number of necessary cellular processes such as DNA 
replication, transcription, and DNA repair. Thus, interstrand crosslinking agents such as cisplatin 
and nitrogen mustards are a common strategy for anti-cancer therapy. The formation of 
interstrand crosslinks is not solely due to human intervention, however. Exposure to 
environmental stresses can lead to their formation, and organisms evolved strategies to 
counteract their formation. The Fanconi anemia pathway is the primary pathway used for 
repairing interstrand crosslinks. Sixteen Fanconi genes have been identified, and when mutated, 
lead to the development of Fanconi anemia syndrome in humans, a disorder characterized by the 




Figure 1.4: Interstrand crosslink repair by the Fanconi anemia pathway.  A. The Fanconi 
anchor complex associates with the DNA lesion. B. The Fanconi core complex (Blue) is 
recruited to the lesion via the anchor complex. The core complex recruits FANCD2/FANCI, 
which are phosphorylated by the ATRIP/ATM complex. C. The phosphorylated D2/CI complex 
serves a recognition site for the endonuclease FAN1, which separates the crosslinked strands. D. 
Translesion synthesis is carried Polζ . E. RAD51 and BRCA2 facilitate strand evasion and H. 




erythroid, myeloid, and lymphoid lineages of blood, and a predisposition to cancer [36].  
  Insterstrand crosslinks are recognized during S-phase by fanconi anemia 
complementation group M (FANCM), which associates with centromere protein S 
(CENPS/MHF1) and centromere protein X (CENPX/MHF2) at sites of damage forming an 
anchor complex on the DNA [37-39] (Figure 1.4A). The core Fanconi complex then is recruited 
to the anchor, which consists of fanconi anemia complementation group E, F, G, C, A, L, B, and 
is responsible for the ubqitination of fanconi anemia complementation group D2 (FANCD2) and 
fanconi anemia complementation group I (FANCI) and the further recruitment of additional 
DNA repair factors [40, 41](Figure 1.4B). FANCD2/FANCI complex is phosphorylated by 
Ataxia telangiectasia mutated (ATM)/ataxia telangiectasia and Rad3-related protein interacting 
protein (ATRIP), leading to stabilization of the complex to the DNA binding [42] (Figure 1.4B). 
The association of FANCD2/FANCI to the DNA leads to its ubiquitination by the core complex 
and recruitment of FANCD2/FANCI-associated nuclease 1 (FAN1), a nuclease that is 
responsible for releasing the crosslinked strand [36](Figure 1.4C). After strand release, 
translesion synthesis is carried out by the error prone DNA polymerase ζ at the site of DNA 
damage [43](Figure 1.4D). The damaged DNA is then repaired by Fanconi specific DNA repair 
factors breast cancer 2 (BRCA2), breast cancer 1 (BRCA1) interacting protein C-terminal 
helicase 1 (BRIP1), partner and localizer of BRCA2 (PALB2), and radiation sensitive 51C 
(RAD51C) as well as factors involved in homologous recombination repair such as BRCA1 and 
radiation sensitive 51 (RAD51)[36](Figure 1.4E,F).  
 It has been demonstrated that FANCD2 can disassemble the histone 3 (H3)/histone 4 
(H4) tetramers in vitro, and FANCD2 depletion leads to alterations in H3 mobility in the genome 
[44]. Recently it has been reported that the FANCD2 contains a reader domain that can recognize 
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H4K20 methylation (unpublished results) [45]. It suggests that histone marks could influence 
ICLR activity by direct interactinons between repair factors and the histone code.  
Single strand break repair 
 
 A majority of single strand DNA breaks arise from endogenous sources of reactive 
oxygen species (ROS) and are repaired by the SSBR pathway. The generation of hydrogen 
peroxide through normal cellular metabolism leads to the formation of free radicals that can act 
directly on DNA by modifying bases. This type of damage is initially repaired by the BER 
pathway. As the BER pathway nears completion of the repair, DNA-(apurinic or apyrimidinic 
site) lyase (APE1) endonuclease initiates the cleavage event that leads to the generation of single 
stranded DNA (ssDNA) (see Base excision repair section) (Figure 1.5A). The ssDNA is 
generated as an intermediate product, and is then funneled into the SSBR pathway.  
ROS exposure can also cause direct excision of the bases generating a gap and a single 
strand break in the DNA that is repaired by SSBR. This type of break is recognized by the 
PARP1 enzyme. PARP1 is a direct sensor of single stranded DNA and binding to ssDNA leads 
to its enzymatic activation in an allosteric fashion [46])(Figure 1.5B). How PARP1 is able to 
rapidly sense single strand DNA breaks on a genome-wide scale can be attributed to the amount 
of the protein present in the nucleus. It is estimated that there is one PARP1 protein for every 20 
nucleosomes. [47]. Activated PARP1 catalyzes the formation of poly(ADP-ribose) chains onto 
H1 and the H3/ H4 tetramers surrounding the DNAdamage site with the aid of histone 
PARylation factor 1 (HPF1) [48]. X-ray repair cross-complementing protein 1 (XRCC1) is 
guided to the site of DNA damage via aprataxin-PNK–like factor (APLF) through its PAR-
binding zinc finger domain were it associates with H3/H4 tetramer and PARP1 [49, 50]XRCC1 
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acts as a scaffold for the recruitment of DNA Ligase III and DNA polymerase β, which fill in the 
gap in the damaged DNA [15, 51](Figure 1.5C). 
Lastly, another source of single strand breaks is abnormal Topoisomerase I (TOP1) 
activity [52]. TOP1 can become permanently linked to DNA at cleavage sites in situations in 
which free radicals have damaged the DNA [53](Figure 1.5A). Covalently fixed TOP1 is cleaved 
from the DNA by Tyrosyl-DNA phosphodiesterase-1 (TDP1) [54]. XRCC1 serves as a scaffold 
between TDP1 and the single strand break repair complex mentioned above [55](Figure 1.5B).  
 It has been observed that PARP1 PARylation activity occurs at the same sites as other 
modifications on core histones. Histone 2A lysine 13 (H2AK13), histone 2B lysine 30 
(H2BK30), histone 3 lysine 27 (H3K27), histone 3 lysine 37 (H3K37), and histione 4 lysine 17 
(H4K17) were identified as sites of PARP1 dependent PARylation [56]. It was found that 
H4K16 acetylation limits PARylation of H4 histones [56]. PARylation could be limited at sites 
of single strand DNA breaks by the activity of lysine acetyltransferase 5 (Tip60), which 
specifically modifies H4K16 at sites of DNA damage [57]. In this scenario, H4 acetylation 
would dampen the DNA damage signal propagated by PARP1 and would in turn limit the 
amount poly(ADP-ribose) chains generated. In this way, histone modifications prevent hyper-
PARylation, which can be lethal to cells experiencing genotoxic stress [48]. It would be 
interesting to explore the effects of different histone modifications on single strand break repair.  
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Figure 1.5: Single strand break repair. The activity of BER generates SSB that are processed 
by the SSBR pathway. A) APE1 introduces a break in one strand following BER. XRCC1, Polβ, 
and LIG3 are recruited to the DNA break site. C) Polβ fills in the gap and (D) LIG3 seals the 
nick. Direct SSB (A) can be generated by ROS activity. B) These lesions are recognized 
PARP1/PARG and (C) recruit PCNA/XRCC1/LIG1 and Polβ fills in the gap and (D) LIG1 seals 
the nick. TOP1 SSB can be generated by TOP1 becoming permanently linked to DNA through 
contact with an abnormal base. B) TDP1 cleaves TOP1 from the DNA generating a SSB, which 
recruits XRCC1 and LIG3. This lesion is then repaired by a similar mechanism as a direct SSB. 
Modified from [9].    
 
Double strand break repair 
 
 DNA double strand breaks are the most rare form genotoxic stress experienced by cells, 
with fewer than two occurring per cells [4]. However, across species, they represent the most 
toxic of lesions with 1-2 unrepaired double strand breaks considered lethal [58]. Mammalian 
studies indicates that 1-10 unrepaired double strand breaks is lethal [59]. 
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  Mammalian cells have evolved a complex signaling pathway to sense and repair DNA 
double strand breaks (Figure 1.6). Kinetics experiments estimate that repair takes place within 3 
minutes and up to 720 minutes, depending on the double strand break repair pathway used [60]. 
The “fast acting” repair pathway identified in early kinetic experiments was hypothesized to 
depend on DNA ligases; and was later named non homologous end joining (NHEJ). The “slow 
repair” pathway was dependent on recombinases and later name homologous recombination 
(HR) [61]. 
 Two independent sensors, PARP1 and X-ray repair cross-complementing protein 6 
(XRCC6/KU70)/ X-ray repair cross-complementing protein 5 (XRCC5/KU80) sense double 
strand breaks and depending on which sensor is utilized, determines which double strand break 
repair pathway is used. PARP1 directly senses double strand breaks after homodimerization 
caused by the discontinuity in the broken DNA [62, 63]. The dimerization of two PARP1 
molecules on opposite sides of a double strand breaks leads to auto-PARylation and this initiates 
a cascade of break sensing [62]. PARP1-mediated PARylation leads to the recruitment of single 
stranded binding homologue 1 (SSB1) and the MRN complex composed of Meiotic 
Recombination 11 homolog (MRE11)/radiation sensitive 50 (RAD50)/NLR family pyrin domain 
containing 2 (NLRP2/NBS1), through association of the PAR binding domains of SSB1 and 
MRE11 [64, 65]. Another study showed that the initial recruitment of MRN to DNA damage 
primarily depends on SSB1, however the PAR binding domain of MRE11 could fine-tune the 
localization of MRN [66]. 
 MRN localization to the double strand break recruits ataxia-telangiectasia 
mutated (ATM), which phosphorylates H2AX on Ser139 (γH2AX) and leads to the recruitment 
of mediator of DNA damage checkpoint 1 (MDC1) [67]. The recruitment of MDC1 to break 
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Figure 1.6: Early events in Double strand break repair.  When a DSB occurs it can be sensed 
by PARP1 or by XRCC5/XRCC6. PARP1 recognition of a DSB initiates the HR repair pathway. 
PARylation of local histones and of PARP1 itself lead to the recruitment of MRN and the 
subsequent phosphorylation of H2AX. The generation of γH2AX leads to the recruitment of 
MDC1, which serves as a platform for the DNA repair machinery to assemble. MDC1 loaded 
ubiquitin proteins work to degrade local proteins expose histone methylation marks necessary for 
53BP1 to bind and the extension of ubiquitin chains recruit the RAP80-BRCA1 complex. Both 
RAP80-BRCA1 and 53BP1 are required for HR to take place. XRCC5/XRCC6 recognition of a 
DSB initiates the NHEJ repair pathway. XRCC5/XRCC6 recruit DNAPKcs to DSB and these 
proteins work to hold the two broken ends in close proximity while XRCC4/XLF/LIG4 is 
recruited to the break site and LIG4 works to seal the broken ends.     
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sites represents a fork in DNA repair pathway utilization and depending on the phase of the cell 
cycle, will dictate whether the NHEJ or the HR repair pathway is used for the completion of the 
repair.  
 MDC1 directed HR and NHEJ repair begins with the same signaling cascade. HR repair 
pathway has two sub-pathways: homology directed repair (HDR) and single strand annealing 
(SSA) [68]. Despite being a part of the HR repair pathway, SSA is always mutagenic. The NHEJ 
repair pathway also has two sub-pathways: classical NHEJ (cNHEJ) and alternative NHEJ 
(altNHEJ), both of which are mutagenic [69].  
 ATM phosphorylation of MDC1 leads to the recruitment of ubiquitin conjugating 
complex containing ring finger protein 8 (RNF8)/ E2 ubiquitin-conjugating protein 13 (UBC13) 
complex[70]. RNF8 recruitment stabilizes jumonji domain containing 1C 
 (JMJD1C), a histone demethylase, at sites of DNA damage, which demythylates MDC1 
allowing for RNF8/UBC13 to add ubiquitin chains to MDC1 [71]. The ubiquitination of MDC1 
then leads to the recruitment of the ubiquitin interaction motif containing 1 
(UIMC1/RAP80)/BRCA1 complex [72, 73]. The RAP80-BRCA1 complex fine-tunes HR repair 
by limiting the length of ssDNA generated by the MRN-BRCA1/retinoblastoma binding protein 
8 (RBBP8/CtIP) complex [72].  
 UBC13, the binding partner of RNF8, extends ubiquitin residues on the linker histone 
H1, which serves as a loading platform for RNF168 [74]. RNF168 and RNF8 work together to 
ubiquitinate and degrade jumonji domain containing 2A (JMJD2A), a histone demethylase, 
which demethylates histone 4 lysine 20 (H4K20) residues [75]. Ring finger protein 168 
(RNF168) binding also leads to the ubiquitination of H2A at K12/K15 [74]. The clearance of 
JMJD2A exposes H3K20me and together with H2A K12/K15 ubiquitination, serves as signal for 
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tumor protein p53 binding protein 1(TP53BP1/53BP1) to bind [76]. The recruitment of 53BP1 
limits end resection carried out by BRCA1-CtIP [77]. In this way, both BRCA1 and 53BP1 fine-
tune the amount of ssDNA generated at break sites.  
 During HR repair, the amount of ssDNA generated following a double strand break will 
influence whether HDR or SSA takes places. If BRCA1 and 53BP1 are correctly coordinated at a 
break site, HR will take place. Currently, the absolute length requirements for HR repair are not 
known. Instead there only exists a nebulous goldilocks idea of length requirements; just the right 
amount leads to HDR and too much results in utilization of the highly mutagenic SSA repair 
pathway.  
 There is no hard-and-fast rule for ssDNA length requirements for HDR and SSA. Instead 
it is more likely the utilization of HDR or SSA depends on the sequence composition of the 
ssDNA and binding kinetics of ssDNA binding proteins. Replication protein A (RPA) is the most 
abundant ssDNA binding protein in the cell and participates in DNA repair [78, 79]. RPA has the 
preferentially binds ssDNA with polypyrimidine tracts of 8 nucleotides in length, and upon 
binding, shifts its conformation to occupy up to 30 nucleotides in a 5ʹ to 3ʹ direction [80]. The 
associated of RPA with ssDNA can generate two structures at the sites of DSBs: one condensed 
structure containing tightly packed RPA coated ssDNA and the other is a linear structure of RPA 
coated ssDNA, and the linear structure requires the ssDNA to be under constant tension 
otherwise it will condense [81]. This observation could provide insight into the utilization of 
HDR over SSA. SSA is mediated by radiation sensitive 52 (RAD52) binding with RPA in a 
concentration dependent manner to facilitate ligation and annealing of homologous sequences 
[77, 82].  
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If the ssDNA generated by end resection is not maintained under sufficient tension, it 
condenses and the local concentration of RPA increases, driving RAD52 binding and leading to 
SSA[81]. Evidence suggests that RAD52 is recruited to DNA break sites via switch/sucrose non-
fermentable (SWI/SNF) Related, Matrix Associated, Actin Dependent Regulator Of Chromatin, 
Subfamily A, Member 4 (SMARCA4/BRG1), the ATPase subunit of the Switch/Sucrose non-
fermentable (SWI/SNF) chromosome remolding complex [83]. In this model, RAD52 is 
sequestered at end of the interface of the double stranded and single stranded region. In order to 
prevent SSA from occurring, the ssDNA would have to remain elongated, thereby limiting the 
local concentration of RPA. The elongated RPA coated ssDNA is a substrate for split hand/foot 
malformation type 1 (SHFM1/DSS1)/BRCA2/RAD51 complex. DSS1 mimics the DNA binding 
substrate of RPA and causes its dissociation from the ssDNA, allowing RAD51 to be loaded in 
its place [84]. The association of RAD51 to the ends of the single stranded DNA is sufficient to 
induce strand invasion and D-loop formation [85]. The formation of the D-loop initiates DNA 
synthesis and the resulting holiday junction can be resolved in two ways; through synthetic 
Lethal of unknown (X) function homolog 1 (SLX1)/ synthetic Lethal of unknown (X) function 
homolog 4 (SLX4) resolvases, or through the Bloom syndrome RecQ like helicase (BLM)/RecQ-
mediated genome instability complex (RMI)/ Topoisomerase (DNA) III Alpha (TOPIIIα) 
pathway [86].  
 The processes of HDR and SSA are not the only repair pathways that require the 
formation of ssDNA. The altNHEJ repair pathway, also known as microhomology mediated end 
joining (MMEJ) requires the generation of ssDNA to function. The mechanics for generation of 
ssDNA is similar to other HR pathways, however the activity of CtIP is uncoupled from BRCA1. 
It was found that the unphosphorylated form of CtIP can perform end resection independently of 
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BRCA1 [87]. The association of CtIP with the MRN complex is sufficient to stimulate end 
resection activity at sites of DNA damage [88, 89]. The amount of homology necessary for 
MMEJ/altNHEJ is estimated to between 1 and 4 nucleotides [90]. However, this is not reflective 
of the actual length of the single stranded DNA generated. It should be noted that the ssDNA 
generated during this process is a substrate for RPA, which limits MMEJ/altNHEJ activity [91]. 
The footprint for RPA binding is 8-30 nucleotides, and the ssDNA generated necessary for 
MMEJ/altNHEJ is at least this long.  
 How then might RPA be bypassed to facilitate MMEJ/altNHEJ? One possible scenario is 
that the initial DNA break detection by PARP1 recruits splA/ryanodine receptor domain and 
SOCS box containing 1 (SSB1), which binds with MRN and stimulates end resection activity 
prior to BRCA1 recruitment [66]. PARP1 directly stimulates MMEJ via recruitment of 
XPF/ERCC1/POLθ and XRCC1/LIG3 complexes [92, 93]. The recruitment of these complexes 
leads to the excision of overhanging ssNDA, gap fill-in, and strand ligation to seal the break. 
 There exists a continuum of ssDNA that facilitates different types of repair: SSA being 
on one extreme and cNHEJ on the other extreme. There exist two pathways for cNHEJ 
activation: the first involves SSB1/MRN brake sensing and the other involves XRCC5/XRCC6 
direct sensing of the double strand break. As mentioned above when SSB1/MRN sense a break, 
it leads to the loading of MDC1 and the recruitment of BRCA1 and 53BP1. Both of these factors 
fine-tune the amount of ssDNA generated at the break site in order to optimize the utilization of 
HDR. If end resection is completely blocked, it is hypothesized that 53BP1 can direct DNA 
repair towards cNHEJ.  
  How 53BP1 facilities cNHEJ is not clear, and little work has been done to address the 
mechanism. However, there is link between 53BP1 and its ability to stimulate cNHEJ. 53BP1 
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interacts with retinoblastoma transcriptional corepressor 1 (RB1), which serves as a scaffold for 
XRCC5/XRCC6 binding [94, 95]. Therefore, a possible scenario is that the rapid accumulation 
of 53BP1 at sites of double strand DNA breaks limits the amount of end resection taking place 
and recruits XRCC5/XRCC6, leading to the activation of the cNHEJ repair pathway. 
 The XRCC5/XRCC6 heterodimer recruits protein kinase, DNA-activated, catalytic 
polypeptide (PRKDC/DNA-PKcs) to the sites of DNA damage in order to keep the two broken 
ends in close proximity. DNA-PKcs localization recruits APE1, tyrosyl-DNA phosphodiesterase 
1 (TDP1), polynucleotide kinase 3'-phosphatase (PNKP), which are required for ligation of the 
broken ends by the XRCC4/XLF/LIG4 complex [96]. The XRCC5/XRCC6 heterodimer is 
hypothesized to directly sense the double strand DNA breaks by its association with the ends of 
DNA with high affinity [97] [98]. However, it is not clear on how XRCC5/XRCC6 rapidly 
detect the double strand break once it occurs. Other DNA damage sensing pathways have 
components that are in high concentration and activity scanning DNA. One hypothesis is that it 
is actively recruited to double strand breaks in a PARP1-dependent manner. Mass spectrometry 
results have identified that XRCC5 was associated with poly(ADP-ribose) molecules [99]. It was 
found that the PAR domain of XRCC6 is required for cNHEJ repair to take place [100].  
 This model for PARP1-mediated XRCC5/XRCC6 recruitment to sites of double strand 
breaks seems at conflict with PARP1 recruitment of HR factors. How can it be that the single 
activity of PARP1 results in two diverging repair pathways? It was found that XRCC5/XRCC6 
heterodimer slides along dsDNA once it has bound to the broken end [98]. It is conceivable that 
XRCC5/XRCC6 mobility is necessary to make room for the binding of other cNHEJ 
components. If the histones in front of XRCC5/XRCC6 can be removed, the complex can slide 
further from the ends of the DNA limiting its ability to recruit other cNHEJ factors and favors 
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other repair pathways dependent on ssDNA. If histone dynamics are restricted at the break sight, 
then XRCC5/XRCC6 movement is restricted, thus keeping the complex in close proximity to the 
break site and favoring cNHEJ activity. However, further test would be needed to determine if 
XRCC5/XRCC6 can interact with histone remodeling factors necessary for removal of histones. 
 
DOT1L and epigenetic control of DNA damage repair 
 
 As mentioned in the above sections epigenetic marks play an important role in 
DNA damage sensing and DNA damage repair. The mechanism of how specific histone marks 
contribute to DNA repair processes remains a poorly understood process. In order to shed light 
on how epigenetic marks facilitate DNA repair we are studying the histone methyltransferase 
disruptor of telomeric silencing-1-Like (DOT1L). DOT1L is the only known histone 3 lysine 79 
methyltransferase in eukaryotes [101-103].   
DOT1L was first identified in the budding yeast as “disruptor of telomeric silencing-1” 
(DOT1) in a genetic screen for genes affecting telomere silencing [104]. Biochemical 
characterization of Dot1 and the mammalian homologue, DOT1L, identified both as 
methyltransferases responsible for the methylation of H3K79 [101-103]. H3K79 methylation in 
eukaryotes is broadly associated with euchromatic regions, and is reduced in regions of 
heterochromatin.  
 Genome-wide studies of histone marks in Drosophila and mammals found that H3K79 
methylation occurs within genes undergoing active transcription [105, 106]. DOT1L has 
experimentally been shown to interact with AF10, and this interaction, in the context of MLL-
AF10 leukemic translocation, has been show to play a role in leukemogenesis [107]. Further 
experiments identified DOT1L as a central component to a transcriptional activation complex, 
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DotCom, which also contains several common MLL fusion partners AF9, AF10, ENL, and AF17 
[108]. 
 Murine hematopoietic cells immortalized with the fusion protein MLL-AF9 show a 
DOT1L dependence on survival [109]. These observations lead to the development of a small-
molecule inhibitor of DOT1L methylation activity that could inhibit the growth of MLL tumors 
in a xenograft mouse model [110]. It is hypothesized that mislocalization of H3K79 methylation 
leads to an activation of a leukemia specific transcriptional program [111]. However, evidence 
from eukaryotes indicates that DOT1L is required for maintaining genome integrity, potentially 
by its involvement in the DNA damage response [112-116]. 
In yeast Dot1 knockout caused activation of the pachytene checkpoint in budding yeast 
[117]. The pachytene checkpoint occurs during meiosis, when non-sister homologous 
chromosomes pair and undergo recombination. Arrest during this phase is termed the pachytene, 
or meiotic recombination, checkpoint [118]. In another study using the same DOT1 deletion in 
yeast, Δdot1, and two other deletions in genes that prevent meiotic double strand break repair, 
Δdcm1, and Δrad54, the yeast bypass the meiotic recombination checkpoint and display an 
accumulation of fragmented chromosomes [119]. These observations suggest that Dot1 plays a 
role in DSB repair via the HR repair pathway and cell cycle checkpoint control. Indeed, yeast 
DOT1 mutants have decreased viability when treated with ionizing radiation (IR) to induce DNA 
damage; and this phenotype was duplicated in yeast strains carrying mutations at H3K79 that 
prevent methylation [120]. Altogether, these results indicate that DOT1L and the methylation of 
H3K79 is important for proper DNA damage response in yeast, and suggests it may be true in 
mammalian cells.  
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 A specific epigenetic modification system exists in yeast and mammals, called trans-
histone modification, in which the deposition of one epigenetic mark facilitates the addition of 
another. Trans-histone modification was identified in yeast Dot1-dependent H3K79 methylation, 
which was demonstrated to require H2B123 ubiquitination via Rad6-Bre1 in yeast [121-123]. In 
budding yeast exposed to IR, it was demonstrated that defects in H2B123 ubiquitination, caused 
by a mutation in Rad6, lead to defects in H3K79 methylation via Dot1, and a subsequent block in 
Rad9 activation [114, 124]. Yeast DOT1 mutants exposed to IR are defective in the G1 
checkpoint and fail to induce the phosphorylation of both Rad9 and Rad53 (the yeast orthologue 
of 53BP1, and homologue of CHK2, respectively) [113]. In this example, the trans-histone 
modification system is necessary for propagation of the DNA damage signal, and by eliminating 
one epigenetic mark, the entire signaling cascade is dysfunctional. DOT1L and DOT1L-
methylation is central to the trans-histone modification and the DNA damage response.  
Further experiments performed with yeast Δdot1 mutants provided mechanistic clues 
regarding the specific DNA damage repair pathways that DOT1L functions in. In the absence of 
Dot1, uncapped telomeres were subjected to hyper end resection [112]. Hyper end resection is a 
phenomenon in which the exonucleases that process broken DNA ends are unchecked and 
generate long sections of ssDNA, which can be problematic because it is a substrate for highly 
mutagenic DNA repair pathways in mammals such as alt-NHEJ and SSA.  
Hyper end resection was observed in non-telomere regions of yeast Δdot1 mutants, where double 
strand DNA breaks were induced using the HO endonuclease [125].  
 The dependence of Rad9 activation on H3K79 methylation led to work in mammalian 
cells, in which it was demonstrated that 53BP1 (the mammalian orthologue of Rad9) recognizes 
H3K79 methylated residues at the sites of DSB [126]. Another report demonstrated that H4K20 
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methylation by CRB2 is responsible for the recruitment of 53BP1 to sites of DSB [115]. Neither 
study ruled out the possibility that both marks are used in co-recruitment of 53BP1. Studies in 
chicken DT40 cells demonstrated that DOT1L deficient cells still form 53BP1 foci upon 
irradiation, thus indicating that 53BP1 is independently loaded onto DSB [127]. Indeed this 
appears to be the case, as it was shown that 53BP1 is recruited to sites of DSB by H2AK15 
ubiquitination via RNF168 and H4K20 methylation [128]. These observations indicate that 
DOT1L  and H3K79 methylation mediates a DNA damage response independent of 53BP1 
activation, and perhaps represents an additional, and novel pathway for DSB repair.  
A unique feature of H3K79 methylation is that it can prevent the nucleosome from 
adopting a compact state [129]. The open state of chromatin facilitated by H3K79 methylation, 
or DOT1L, itself could allow histone exchange , thereby allowing DNA repair to happen. 
 The link between DOT1L and histone exchange comes from experiments in mammalian 
cells implicating DOT1L in complex with factors involved in histone remodeling. First, DOT1L 
forms a complex with v-myc avian myelocytomatosis viral oncogene homolog (c-Myc) and 
CREB-binding protein/ E1A binding protein p300 complex (CBP/p300) [130]. We term this 
complex MyDOT for simplicity of explanation. The CBP/p300 component of MyDOT acetylates 
several histone residues including H3K14, H3K18, H3K23, H3K27, H3K56, H4K5, H4K8, 
H4K12, and H4K16, creating marks for the recruitment of downstream factors [131-133]. The 
DOT1L component of MyDOT is the sole methyltransferase responsible for the methylation of 
H3K79.  
 In the absence of DOT1L, c-Myc forms a repressive complex with HDAC1, a histone 
deacetylase, and the DNA methyltransferase DNMT1 [130]. HDAC1 can remove acetylation 
marks from a variety of locations including H3K9, H3K14, H4K5, H4K8, H4K12, and H4K16 
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[134. The residues H4K5, H4K8, H4K12, and H4K16 were also shown in yeast to be important 
for H2AZ deposition {Altaf, 2010#360]. Furthermore, c-Myc forms a complex with the histone 
acetyltransferase Tip60 and the histone remolding factor E1A binding protein p400 (p400), 
which acetylates H4K16 and catalyzes the exchange of H2AZ respectively [57, 135, 136]. Both 
Tip60 and p400 participate in active histone exchange during DNA damage detection and repair 
[137]. Finally c-Myc has been shown to directly inhibit cNHEJ by binding to XRCC6 (KU70) in 
the XRCC5/XRCC6 (KU80/KU70) complex and blocking DNA-PKc association with XRCC6 
(KU70) [138]. Therefore, it is conceivable that the repressive c-Myc/HADC1/DNMT1 complex 
could inhibit H2AZ exchange at sites of double strand breaks, by removing key acetylation 
marks.  
 These observations form the basis for the following model for the role of DOT1L in 
DNA damage repair: 1) the MyDOT complex is rapidly recruited to sits of DNA damage via its 
interaction with XRCC6 (KU70); 2) concurrently, MDC1 is recruited to the break site with 
Tip60/p400; 3) together MyDOT and MDC1/Tip60/p400 work to acetylate and methylate 
histones, which facilitate the exchange of H2AZ into chromatin (Figure 1.7). Using this model, 
we predict that in the absence of DOT1L, the repressive c-Myc/HDAC1 complex will form, 
leading to deacetylation of H3 and reducing the efficiency of H2AZ incorporation by  
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Figure 1.7: Hypothetical MyDOT DNA repair complex. The MyDOT complex consisting of 
c-Myc, DOT1L, and CBP/p300 is rapidly recruited to sites of DSB via c-Myc interaction 
XRCC5/XRCC6. MyDOT, together with Tip60/p400 complex methylates (black dots) acetylates 
(red dots) the local histones to shift them into an open confirmation that is permissive for H2AZ 
exchange. In the absence DOT1L c-Myc forms a complex with HDAC1, which actively 
deacetylates histones, which prevents efficient H2AZ exchange. It is hypothesized that a 
catalytically inactive DOT1L would have a similar effect as a absent DOT1L as the methylation 
mark could act to block deacetylation activity or facilitate the acetylation.  
Tip60/p400. Consequently, an increase in end resection activity will result at DNA damage sites, 
eventually leading to genomic instability. In the absence of DOT1L H3K79 methylation activity, 
the MyDot complex will be catalytically inactive, but still facilitate acetylation at the break site. 
However, the absence of H3K79 methylation could allow for the binding of a deacetylase, such 
as sirtuin 3 (SIRT3), which has been shown deacetylate H3 marks associated with DNA damage 
[139]. Indeed, in yeast it was found that H3K79 methylation can activity block the activity of the 
Sir3 deacetylase [140]. The H3 deacetylation inhibits H2AZ incorporation at sites of DNA 
damage. 
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 Based on the MyDOT model for DNA damage repair, we hypothesize that in the absence 
of DOT1L or DOT1L methylation activity, DNA repair would be deficient. Specifically, DOT1L 
mutants are hypothesized to have defects in H2AZ incorporation, hyper end resection, and 
defects in DNA repair pathway utilization. Our model provides the potential for novel 
mechanistic insight in the function of an epigenetic regulator in the DNA repair processes. 
 To test our hypotheses, we used a combinatorial approach that bridges the fields of 
biology and computer science. In the following three chapters I will outline three methodologies 
developed to test the hypotheses. These methodologies include a novel chromatin 
immunoprecipitation (ChIP) technique that allows for the identification of nucleosomes at DNA 
double strand break sites in a sequence-independent manner. We also developed a methodology 
for measuring single stranded DNA, down to nucleotide resolution. Finally, we developed a 
machine autonomous approach to analyzing microscopy images that incorporates cell cycle data 
with nuclear foci kinetics. In the fifth chapter I demonstrate the application of these 
methodologies to elucidate the molecular mechanism of DOT1L function in DNA repair. This 
approach has led to the discovery of a potential molecular mechanism of DOT1L function in 
DNA repair. Identification of the molecular mechanism of DNA repair regulated by DOT1L will 
provide foundation for the improved development of molecular therapy programs designed to 
induce DNA damage. 
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Chapter II: Identifying nucleosome dynamics at sites of double strand break 
Abstract 
 Understanding histone dynamics at sites of DNA damage is central to understanding how 
DNA repair takes place, however, assays for histone dynamics at DNA breaks sites lack the 
temporal resolution necessary to interrogate a rapid and dynamic phenomenon. Here, we present 
“broken end ligation chromatin immunoprecipitation” (BEL-ChIP), a method that combines in 
situ hybridization with chromatin immunoprecipitation. BEL-ChIP allows for the identification 
of histones, histone variants, and epigenetic marks that are present at sites of DNA double strand 
breaks independent of the underlying DNA sequence. BEL-ChIP will allow for unprecedented 
temporal resolution of protein composition and modification at sites of double strand breaks. 
Introduction 
 Histone variants and epigenetic marks help guide DNA repair machinery within cells. 
Chromosome immunoprecipitation (ChIP) is the main technique to map proteins and epigenetic 
marks to the genome; however, ChIP cannot be used to identify random double strand breaks. 
ChIP in combination with zinc finger nucleases have been used to map chromosome dynamics at 
specific break sites [136]. However, using ZFN or CRISPR/Cas9 systems are temporally limiting 
with the interrogation of break sites usually occurring > 24 hours after transfection, and a prior 
knowledge of the sequence surrounding the break site is required for qPCR. To map double 
strand breaks, independent of sequence composition, Direct in situ breaks labeling, enrichment 
on streptavidin and next-generation sequencing (BLESS) was developed [141]. BLESS allows 
for the mapping of double strand breaks with high resolution using a broken end capture 
technique combined with next generation sequencing. Despite this advancement for identifying 
locations of double strand breaks in a sequence independent manner with high temporal 
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resolution, there is missing a comparable technique for protein composition and modification. 
Therefore, an improved method for identifying protein composition and modifications with 
higher temporal resolution is needed. 
 To address these problems, we developed BEL-ChIP, a method using a modified version 
of the in situ labeling of BLESS, and the temporal control of double strand break induction using 
ionizing radiation (Figure 2.1a). In BEL-ChIP, labeling of double strand breaks occurs in situ in 
the nucleus before lysis, minimizing possible labeling of new double strand breaks introduced 
through sample processing. ChIP is then performed on the linker labeled library, directly 
capturing the monosome that contains protein or epigenetic mark of interest. qPCR is applied to 
the enriched library using adaptors that are specific for the broken end linker. The BEL-ChIP 
protocol is robust, reproducible, and can be completed in a few days (Figure 2.1a). 
Material And Methods  
Cell Lines 
 Wild type HEK293T cells were purchased from ATCC. Mutant HEK293T DOT1LSTOP 
and DOT1LY312A are described elsewhere (Chapter IV). 
Cell Culture 
 Wild type HEK293T and mutant HEK293T DOT1LSTOP and DOT1LY312A cell lines were 
maintained in 10% FBS, DMEM, Pen/Strep in 37 oC, 5% CO2.  
Primers and adapters 
Broken End Linker TACTACCTCGAGTAGGGATAACAGGGTAATTTTTTATTACCC 
TGTTTATCCCTACTCGAGGTAGTA 
Anchor Linker CGTCGTCTCGAGTAGGGATAACAGGGTAATTTTTTATTACCC 
TGTTTATCCCTACTCGAGACGACG 
BEL Primer TTATCCCTATCTCGAGGTAGTA 




 The Broken end linker and Anchor linker (IDT) were annealed using T4 DNA Ligase 
Reaction Buffer (#B0202S, New England Biolabs) to a final concentration of 10µM. The 
reaction was heated to 98oC for 5 minutes and allowed to cool to room temperature at 1oC per 
minute.  
BEL-ChIP nuclear extract preparation steps 
 Wild type HEK293T and mutant HEK293T DOT1LSTOP and DOT1LY312A cell lines were 
plated into 10 cm dishes two days prior to treatment of ionizing radiation. On the day of 
experiment, cells were trypsinized, neutralized with 500 µL 10% FBS, 1X DMEM, and 
centrifuged at 300xg for 7 minutes to pellet. Cells were treated with 10 Gy ionizing radiation 
following manufactures recommendations. Cells were gently resuspended and placed in a 37 oC, 
5% CO2 incubator for 60 minutes. Fifty four µL 37% Formaldehyde (2% Final conc.) was added 
to the sample, and incubated with constant rotation at room temperature for 30 minutes. 62.5 µL 
of 2 M Glycine (125 mM) was added to the samples and incubated with constant rotation at 
room temperature for 5 min. Cells were pelleted at 300xg for 7 minutes at 4 oC and then washed 
three times with ice cold PBS (-Ca2+,Mg2+). Cells were resuspended in 1mL of ice cold Buffer A 
+ 0.5 µL 1M DTT + 5 µL 200X PIC (SimpleChIP Kit #9003, Cell Signaling Technology) and 
incubated on ice 10 minutes with mixing every 3 minutes. Cells were harvested at 3000 rpm for 
5 minutes at 4 oC. The pellet was washed 3X with 500 µL NEBuffer 2.1 (#B7202S, New 
England Biolabs). The pellet was resuspended in 88 µL of NEBuffer 2.1, 10 µL dNTP (1mM, 
#N0446S, New England Biolabs), 2 µL T4 DNA Polymerase (#M0203S,New England Biolabs). 
The reaction was incubated at RT for 45 minutes with gentle mixing every 5 minutes. The 
sample was then washed 3X with 500 µL ice cold T4 DNA Ligase Reaction + 0.1% Triton X100 
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(#T8787, Sigma Aldrich). The pellet is then washed once with 500 µL T4 DNA Ligase Reaction 
Buffer. The pellet was resuspended in 18.5 µL T4 DNA Ligase Reaction Buffer with 5 µL of 
10µM annealed Broken end linker and 1.5 µL T4 DNA Ligase (#M0202S, New England 
Biolabs). The reaction was incubated 18-20 hours at 16 oC with constant mixing. The samples 
were washed 3X with T4 DNA Ligase Reaction + 0.1% Triton X100. The pellets were 
resuspended in 100 µL ChIP Buffer (SimpleChIP Kit #9003, Cell Signaling Technology), 2 µL 
RNAse A (10mg/mL, # EN0531, ThermoFisher Scientific) and sonicated 30 seconds on and 30 
seconds off for 45 minutes at 4oC (sonicator brand). Samples were centrifuged at 10,000 rpm for 
10 minutes at 4 oC, transferred to new tubes and frozen at -80 oC.  
Chromatin immunoprecipitation (ChIP) 
 ChIP was performed using an amount of BEL-ChIP nuclear extract corresponding to 3.4 
µg of input genomic DNA in 250 µL of ChIP Buffer + 1X PIC (SimpleChIP Kit #9003, Cell 
Signaling Technology). Antibody was added to manufacture specifications and incubated 
overnight with end over end mixing at 4 oC. 30 µL magnetic protein G beads (SimpleChIP Kit 
#9003, Cell Signaling Technology) were added to the samples and incubated at 4 oC with end 
over end rotation for 4 hours. A magnetic rack was used to collect the beads and the sample was 
washed 2X with 500 µL NEBuffer 2.1. The beads were resuspended in 100 µL of NEBuffer 2.1, 
10 µL 1mM dNTP, 2 µL T4 DNA Polymerase and incubated at room temperature for 25 minutes 
with constant shaking. The beads were placed in a magnetic rack to clear the supernatant and 
washed 2X with 500 µL ice cold T4 DNA Ligase Reaction Buffer. The beads were resuspended 
50 µL T4 DNA Ligase Reaction Buffer with 5µL of 10µM annealed Anchor linker and 1.5 µL 
T4 DNA Ligase. The sample was incubated overnight at room temperature with constant 
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shaking. The beads were washed and DNA was purified following the SimpleChIP Kit 
procedure.  
I-SceI Digest 
 Purified DNA from the ChiP procedure (25 µL) was digested with 1 uL of I-SceI 
endonuclease (#R0694S, New England Biolabs) for 1 hour and heat inactivated.  
PCR 
 PCR of 10 cycles and annealing temperature 61oC was performed using Q5 High-Fidelity 
DNA Polymerase (#M0491S, New England Biolabs) and BEL and AL primers on 5µL of I-SceI 
digested DNA purified from the ChIP procedure. 
Gel Purification 
 PCR reactions were run on a 2% agarose gel (NuSieve™ GTG™, Lonza) and the 200-
400 bp region was excised and purified using a QIAquick Gel Extraction Kit (#28704, Qiagen).  
qPCR. 
 qPCR was performed using Power SYBR® Green PCR Master Mix (#4367659, 
Thermofisher Scientific), BEL and AL primers with annealing temperature of 61 oC and 40 
cycles on ABI 7900 system. Two-tailed Student’s t-test was used for significance testing.  
Antibodies 
 H2AZ (#2718, CellSignaling), H4K acetylation (#ab7311, Abcam).  
Results 
 We were interested in understanding the histone and histone modification kinetics at sites 
of double strand breaks. We performed BEL-ChIP on H2AZ and H4K acetylation in wild type 
HEK293T cells, as well as two mutant HEK293T cell lines DOT1LSTOP and DOT1LY312A 60 
minutes post ionizing radiation treatment to test our method. Similar to in situ ligation (ISL) for  
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Figure 2.1: BEL-ChIP overview and linker design. A. BEL-ChIP begins with the generation 
of DSB using ionizing radiation. Cell are harvested and an in situ ligation is performed using the 
Break linker (B) to label the broken end of DNA. Sample is then processed as a normal ChIP 
procedure. After IP there is an on column ligation step that uses the Anchor linker in (B). The 
addition of Anchor linker allows for interrogation of enrichment of factors at break sites without 
having to know were the break occurred.  
 
labeling double strand breaks occurring during apoptosis and BLESS, our method relies on direct 
in situ labeling of induced double strand breaks. However, the design of the hairpin linkers was 
modified based on knowledge acquired from in situ ligation experiments designed to label 
apoptotic cells [142]. It was found that loopless hairpins have minimal to no background 
staining, however these require a special modification to the ends to hairpins and for our 
experiment the modifications are not needed [143]. Therefore, we initially chose a hairpin loop 
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size of 5 nucleotides, because we reasoned this was reasonable tradeoff between longer stem 
loops that have higher nonspecific background, and smaller stem loops that might introduce 
steric hindrance in hairpin formation (Figure 2.1B). A possible area of improvement would be to 
determine the minimum loop size needed for linker adaptors. This would be especially important 
as the sensitivity of the assay is increased from qPCR to deep sequencing.  
 In ChIP protocols it is standard practice to generate a distribution nucleosomes that 
spread from monosome, disome, trisome and beyond. Since we were interested in the 
nucleosome composition immediately adjacent to the break site, it was necessary to generate 
monosomes. Enzymatic treatment of formaldehyde crosslinked nuclei with micrococcal nuclease 
is a common method to fragment genomic DNA between nucleosomes. However, using 
micrococcal nuclease would result in the cleavage of the broken end linker. Therefore we settled 
on a sonication method that robustly generated a large monosome population (Figure 2.2A). We 
tested whether the monosome population retained the broken end linker by ligation of a second 
linker to monosome followed by PCR. We were able to demonstrate that the sonication 
technique did not remove the broken end linker, as we were able to use PCR to amplify labeled 
monosomes (Figure 2.2B).  
 After generation of the monosome population using sonication, labeled nucleosomes 
were enriched using immunoprecipitation. Immunoprecipitation can be performed using 
antibodies against core histones or the epigenetic marks associated with them. We performed 
immunoprecipitation of the histone variant H2AZ and the H4K acetylation because they both 
play a role in double strand break repair [136, 144]. Immunoprecipitation of H2AZ, H4K 




Figure 2.2: BEL-ChIP sonication and linker stability test. A. Lad, DNA loading ladder; NoL, 
monosome generation from sonication; BL, monosome generation of from sample with the BL 
linker ligated; PCR NoL and PCR BL, PCR using primers specific for BL. This demonstrates 
that a single linker ligation is insufficient for amplification. B. BL sonication stability test. After 
sonication 10 ng of total BL labeled genomic DNA was ligated with the AL and PCR amplified.    
genomic DNA extract using a standard ChIP protocol with modifications (Methods). Prior to 
elution of DNA from the bead:antibody:target complex, a second adaptor was ligated to the 
enriched DNA fragments. The second hairpin loop linker adds a known sequence to allow for 
PCR amplification without knowing the underlying genomic sequence.  
 After purification of the immunoprecipitation, we removed the hairpins using the I-SceI 
endonuclease and PCR amplified with 10 cycles of amplification. In order to enrich for products 
corresponding to monosomes, we gel purified the PCR products between 200-400 base pairs. We 
performed qPCR and found the differential incorporation of H2AZ at sites of double strand 
breaks between our wild-type and mutant cell lines (Chapter V, Figure 5.17A). H4K acetylation 




 We have applied BEL-ChIP to study the dynamics of H2AZ and H4K acetylation at sites 
of double strand breaks. We envision that BEL-ChIP can be used to study histone and histone 
modification kinetics following the induction of double strand breaks. Coupling BEL-ChIP with 
ionizing radiation allows for more precise control of the timing of double strand breaks. This 
offers a significant improvement over the recent uses of CRISPR/Cas9 and zinc finger nuclease 
induction of breaks because the timing of the break induction cannot be completely known. 
Though qPCR is used to quantify the dynamics at breaks site, the application of next generation 
sequencing would allow for the genome wide view of histone exchange at sites of DNA double 
strand breaks. It is now possible to map the exchange of all histones and their modifications for 
which there are antibodies using BEL-ChIP. This methodology will give an unprecedented view 
of the topology of histones and epigenetic marks involved in DNA repair. 
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Chapter III: Measuring DNA end resection using Oxford Nanopore sequencing 
Abstract 
 Nanopore sequencing developed by Oxford Nanopore Technologies allows for the rapid 
sequencing of long DNA molecules of heterogeneous lengths. During the process of DNA repair, 
cells will actively recess DNA ends surrounding the DNA break sites in a process termed “end 
resection”. End resection is necessary for the process of homologous repair to take place, and 
alterations in end resection can have drastic effects on the type of DNA repair pathway utilized. 
Hyper and hypo end resection can drive highly mutagenic repair pathways. The current 
methodologies have genome-wide capabilities, but lack resolution, or have high resolution but 
require prior knowledge of break location. We developed a novel methodology that allows for 
nucleotide level resolution of end resection in genome-wide manner.  
Introduction 
 An ideal approach for measuring the kinetics of end resection following DNA damage is 
to allow for the selection of single stranded DNA molecules from a pool of double stranded 
DNA with minimal processing. The current methodologies used for measuring end resection are 
complex, but not ideal, and are limited by requiring either prior knowledge of DNA break sites 
(as with qPCR assays) or with zero nucleotide resolution (as with DNA stretching) [145, 146]. 
Furthermore, it is difficult to control the timing of DNA break induction; such is the case with 
over expression of endonucleases or treatment with genotoxic drugs. An ideal situation is the use 
of ionizing radiation, however, the location of the double strand breaks is unknown. Genome-
wide sequencing could be used to identify hot spots of mutation after ionizing radiation and these 
regions could be used for qPCR primer design. However, this approach is complex, laborious, 
and prohibitively expensive.  
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 An improved method would facilitate sequencing of enriched single strand DNA 
molecules from cells in which the DNA damage could be precisely controlled. Unlike the 
previous methods mentioned, applying Nanopore sequencing to this problem would allow for 
sequencing long regions of single stranded DNA generated after induction of double strand 
breaks, without knowing the sequence composition beforehand. 
 To generate single stranded DNA that is a product of end resection, cells are exposed to 
ionizing radiation. This allows for fine control over the timing of DNA damage; far better than 
can be achieved with over expression of endonucleases and genotoxic drugs. The enrichment of 
single stranded DNA from double stranded DNA introduces a significant barrier. Solid phase 
reversible immobilization methods (SPRI) are capable of purifying single stranded DNA, 
however, only from a starting population of pure single stranded DNA. This is because the same 
chemistry that drives binding of double stranded DNA works on single stranded DNA. 
Furthermore, the single stranded DNA generated from end resection is not a free molecule, rather 
it is covalently linked to the end of double stranded DNA. To that end we developed a method 
that liberates the single stranded region from the double stranded region while eliminating the 
double stranded DNA, thus yielding a pool of enriched single stranded DNA. The single stranded 
DNA is not by itself amenable for analysis and therefore we developed a method for converting 
single stranded DNA into double stranded DNA in a sequence independent manner.  
 Because the location of breaks cannot be precisely known when using ionizing radiation, 
this eliminates the utility of qPCR based approaches. Instead, a method that allows for the 
measurement of single stranded DNA in sequence independent manner is required. Next-
generation sequencing platforms such as Illumina could allow for the identification of genomic 
regions contained within the single stranded DNA. However, the measurements generated from 
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an Illumina platform require a genome to align against in order to calculate length. This is a 
severe limitation, as it has an assumption that the gene model being used is a true gene model. A 
better methodology would be to measure the length of a single stranded region in a genome-
independent manner. Cloning of the single stranded region into a restriction enzyme independent 
vector such as TOPO (Invitrogen) coupled with Sanger sequencing would provide a genome-
independent measurement of length. However, this approach has several severe limitations. First, 
the length of single stranded DNA would have to be under the maximum sequencing length of 
the Sanger method (<1000 nt). The cloning method employed has a selection pressure on the size 
of the molecules inserted into the vector; this could severely skew the measurement of length 
that is independent of any experiment designed to test end resection rates. Lastly, the cost to 
sequence individual molecules of single stranded DNA using Sanger is significantly higher than 
using Illumina platforms.  
 Current widely adopted sequencing technologies are not suitable for measuring the length 
of single stranded DNA generated from end resection. Therefore, we applied Nanopore 
sequencing technology to overcome this problem. Nanopore technology works by passing a 
nucleic acid molecule through a pore anchored in a membrane. By measuring the voltage change 
as the nucleic acid transients the pore, the bases of the molecule can be determined. The benefit 
of this technology for measuring single stranded DNA is that it can measure the full length of a 
nucleic acid molecule in a genome-independent manner and the read lengths are incredibly long, 
in some cases exceeding 100 kilobases [147]. Utilizing Nanopore technology allows for length 
measurement of individual nucleic acid molecules at nucleotide resolution in a genome 
independent manner.  
Materials and Methods 
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Cell Lines 
 Wild type HEK293T cells were provided by ATCC. Mutant HEK293T DOT1LSTOP and 
DOT1LY312A are described else were (Chapter IV). 
Cell Culture 
 Wild type HEK293T and mutant HEK293T DOT1LSTOP and DOT1LY312A cell lines were 
maintained in 10% FBS, DMEM, Pen/Strep in 37 oC, 5% CO2.  
Enrichment of ssDNA 
 Wild type HEK293T and mutant HEK293T DOT1LSTOP and DOT1LY312A cell lines were 
exposed to 10 Gy of ionizing radiation and total genomic DNA was isolated at 60 and 240 min 
post radiation exposure. Genomic DNA was isolated by adding resuspending cell pellets in 50 
µL of Extraction buffer (Tris-HCl, pH 9.5, 0.1M, KCl 0.25M,EDTA 0.01M), 10 µL Proteinase K 
(20mg/mL), 10 µL RNAseA (10mg/mL). The samples were incubated at 55OC for 15 minutes 
and ethanol precipitated. The extracted DNA was digested with RNAseA and dsDNA overnight 
at room temperature. The samples were ethanol precipitated and twice. 
Coversion of ssDNA to dsDNA 
 ssDNA was converted to dsDNA using the following reaction 5 µL dNTP, 2µL 
AMPLigase, 2µL T4 DNA polymerase, 10µL Random hexamer, 5 µL Ligase buffer. Reaction 
was incubated at 25oC for 10 min and 16oC for 16 hrs.  
Results 
 In our approach to measuring single strand DNA following induction of DNA damage, 
we first developed a method to isolate single stranded DNA from cells that have been treated 
with ionizing radiation. We first developed a method that would extract DNA from cells with as 
little to no mechanical manipulation. We used a high salt/Protease K/RNaseA method for 
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extraction of total DNA. The benefit of this method over others is that it allows for near total 
removal of proteins and RNA from the sample in a short amount of time. The remaining nucleic 
acids were precipitated.  
 To enrich single stranded DNA, it is necessary to differentiate between true single 
stranded DNA and contaminations of genomic DNA in a reverse transcriptase reaction. To 
accomplish this, we employed the use of a genetically engineered DNase, dsDNase 
(Thermoscientific), which specifically and robustly digests double stranded DNA. We used 
dsDNase and RNase to further enrich for single stranded DNA. 
 Currently, single stranded DNA alone is not amenable for sequencing using Nanopore 
technology and requires double stranded DNA for both physical tethering to the pore complex, 
and sequencing both strands of double stranded DNA results in fewer sequencing errors. 
Therefore we developed methods to convert single stranded DNA to double stranded DNA in a 
non-amplifying manner. The first problem we encountered was the generation of a complement 
strand without prior sequence knowledge. We utilized methodologies used for reverse 
transcription, and employed random hexamer primers to prime the single stranded DNA. The use 
of random hexamers allows for the priming of regions whose sequence is not known. Typically, 
random priming is coupled with a strand displacing polymerases. Polymerases with strand 
displacement activity allow for the amplification of low abundant molecules in RNA and DNA 
populations. However, an undesired effect of strand displacing polymerases is the amplification 
of specific regions over others. This is a result of the increased frequency of the occurrence of 
some hexamers over others in the genome. We desired to only generate one complete 
complement strand per single stranded DNA molecule. Therefore, we employed a non-strand 
displacing DNA polymerase, T4 DNA polymerase (New England Biolabs) in conjunction with a 
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DNA ligase used for second strand cDNA synthesis. In this way complement strand generation 
can be conceptualized as a fill-in method. The final step in our library preparation is to ligate 
hairpin adaptors to the each end of the molecules, which allows for the amplification library.  
 We applied this methodology to analyze end resection in wild-type, DOT1LStop and 
DOT1LY312A mutant HEK293T cell lines. The yeast Δdot1 mutant has a hyper end resection 
phenotype, however, this has not been observed in mammals. We exposed wild-type, DOT1LStop 
and DOT1LY312A mutant HEK293T cell lines to 10 Gy of radiation and isolated nucleic acids 
following 60 minutes and 240 minutes (see Methods details). We converted the single stranded 
DNA into a double stranded sequencing library and PCR amplified the library (Chapter V, 
Figure 5.18). We followed the manufacture specifications for library preparation for Nanopore 
sequencing and barcoding. We barcoded each sample (nine in total) and combined them to 
generate a single library for sequencing.  
 Sequencing was carried out as described in the manufacture’s protocol for Nanopore 
sequencing. Metrichor (Metrichor.com) was used to call bases from the MinION sequencer. 
MinION sequencing output decreases with time because contact with the nanopores is driven by 
diffusion (Figure 3.1a). We added new sequencing library at 7.5 and 12.5 hours, as indicated by 
the uptick in yield at those time points (Figure 3.1a). The total yield for the sequencing run was 
73.78 million bases from approximately 19,582 individual molecules (Figure 3.1b). The average 
read length was 2.17 kb with the longest read to be 70.46kb. Quality scores for Nanopore reads 
are given in qscores with values from 0-14; 0 being the worst and 14 the best. The average 
qscore for the sequencing run was 9.7, which is above the cut off of 9. The quality of the reads 
did not decrease with time and remained the same through the course of the sequencing run 
(Figure 3.2a). A majority of the sequenced DNA was below four kilobases, and sequencing reads 
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below a qvalue of 9 were discarded (Figure 3.2b). Sequencing reads were further processed to 
identify the ones that only contained barcodes (Figure 3.3).  
 We compared the length of single stranded DNA from wild-type, DOT1LStop and 
DOT1LY312A mutant cells at different time points. We identified sequences that were common in 
wild-type and DOT1LStop mutant samples at each time point and plotted their distributions 
(Figure 3.4a). We performed the same comparison on the wild-type and DOT1LY312A mutant 
(Figure 3.4b). The overall distribution of lengths between the mutants and wild type are similar 
(Figure 3.4). However, DOT1LStop and to a lesser extent DOT1LY312A mutants have more 
sequences in the range of 2700-3200 bases than wildtype at 60 and 240 minutes post ionizing 
radiation (Figure 3.4). DOT1LY312A mutants also have more sequences 3500 bases, indicating this 
mutant can generate longer single strand DNA than wild-type after DNA damage (Figure 3.4).  
 These observations are similar to what we observed globally using a PCR assay (Figure 
5.18, Chapter V), however, the PCR assay lacks resolution of sequencing. We wanted to test the 
hypothesis that a lack of DOT1L and its methylation activity will generate longer single stranded 
DNA after DNA damage. We compared the mean differences in lengths between regions of 
single stranded DNA that were common between the wild-type and DOT1LSTOP mutant, and the 
wild-type and DOT1LY312A mutant, (Figure 3.5,3.6).  
 We analyzed all the common sequences between wild-type and DOT1LSTOP mutant and 
found that DOT1LStop mutant has more single stranded DNA than wild-type at 60 and 240 
minutes post radiation treatment (Figure 3.5a vs. b). A similar analysis was performed on 
common sequences between wild-type and DOT1LY312A mutant (Figure 3.6). We found that rates 
of ssDNA generation are similar between the two, but the DOT1LY312A mutant generations longer 
ssDNA at 60 minutes post irradiation (Figure 3.6a vs b). 
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 It is of note that at 60 minutes post irradiation we identified that DOT1LStop and 
DOT1LY312A mutant cells have defects in H2AZ incorporation at sites of DNA damage (Chapter 
V, Figure 5.17). H2AZ is a factor that has been shown to limit end resection activity [136]. Our 
observations of H2AZ incorporation defects coupled with identification of ssDNA generation 
defects provide a link between histone variant exchange and end resection activity.  
Discussion 
 We have applied Oxford Nanopore sequencing technology to study the kinetics of end 
resection following the induction of double strand breaks. We envision that this methodology 
will allow for more accurate measurement of end resection kinetics. The nucleotide resolution of 
sequencing allows higher resolution measurements on a genome wide scale, which is currently 
not possible with current methods for measuring end resection activity 
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Figure 3.1: Oxford Nanopore sequencing report. A. Basepair yield over the course of the 
sequencing run. B. Summary table for sequencing metrics for the run.  
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Figure 3.2: Oxford Nanopore sequence length vs quality report. A. 2D sequencing data 
quality score vs. time graph. The x-axis is the time since start of experiment and the y-axis is the 
mean quality score (qscore). B. 2D sequence length vs quality score. The x-axis is the mean 




Figure 3.3. Oxford Nanopore barcode recovery report. A. Number sequences recovered for 
each barcode. BC1-BC3 wild-type samples no irradiation control, 60 and 240 minutes post 
ionizing radiation. BC4-BC6 DOT1LSTOP samples no irradiation control, 60 and 240 minutes post 
ionizing radiation. BC7-BC9 DOT1LY312A samples no irradiation control, 60 and 240 minutes 





Figure 3.4. ssDNA length distribution for wildtype and DOT1L mutants. A. The distribution 
of ssDNA lengths all the common sequences between wildtype and DOT1LSTOP mutant cells 
untreated, or 60 and 240 minutes post radiation treatment. B. The distribution of ssDNA lengths 
all the common sequences between wildtype and DOT1LY312A mutant cells untreated, or 60 and 





Figure 3.5. DOT1LSTOP mutant generates longer ssDNA faster than wild-type cells. A. Plot 
of the difference in length between ssDNA that was identified as longer in the wild-type cells 
compared to the DOT1LSTOP. B. Plot of the difference in length between ssDNA that was 
identified as shorter in the wild-type cells compared to the DOT1LSTOP. 
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 Figure 3.6. DOT1LY312A mutant has longer ssDNA then wild-type cells. A. Plot of the 
difference in length between ssDNA that was identified as longer in the wild-type cells compared 
to the DOT1LY312A. B. Plot of the difference in length between ssDNA that was identified as 




Chapter IV: Application of a Deep Neural Network for DNA Damage Analysis 
Abstract 
 
High-resolution fluorescence microscopy is commonly used to investigate complex 
dynamic processes such as chromosome organization, transcription factor recruitment, and DNA 
damage factor localization. High-throughput automated confocal microscopes can generate large 
amounts of data, yet tools used to analyze the data have remained largely rudimentary. A 
majority of microscopy image data analysis is still carried out manually. Here, we describe 
MANA (Machine autonomous nuclei analyzer), an image analysis pipeline used to identify and 
quantifiy nuclear coalescence events. We developed an analysis pipeline that utilizes machine-
learning methods with state-of-the-art 2D and 3D image processing algorithms for the 
simultaneous staging of the cell cycle and quantification of nuclear localization events. 
Incorporation of cell cycle data allows for the analysis of asynchronous cell populations and 
eliminates the need to use exogenous agents for synchronization. We demonstrate the utility of 




 The various DNA repair pathways present in cells facilitate genome maintenance. Two 
major DNA repair pathways exist to enable the repair of DNA damage, non-homologous end 
joining (NHEJ) and homologous recombination (HR). NHEJ is restricted to the G1/G0 phase of 
the cell cycle, while HR is utilized during S/G2 phase [148]. The evidence for cell cycle 
dependent DNA repair pathway usage has led to a call for the abandonment of asynchronous 
cultures in the study of DNA repair pathways [149].  
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 There are technological hurtles to synchronizing cells in culture, and these involve the 
utilization of drugs that can introduce DNA damage. For example, Aphidicolin, used to 
synchronize cells in G1/G0 can introduce DSB via replication stress [150]. Etoposide, used to 
synchronize cells in G2 also introduces DSBs [151]. The use of genotoxic drugs for cell 
synchronization only confounds the interpretation of data. A more desirable experimental set up 
is to use asynchronous cultures and separate cells for analysis into cell cycle stages. Escribano-
Diaz and collegues utalized the Fucci system in cobination with FACS to study DNA damage 
reponse in specific phases of the cell cylce [148]. The Fucci system allows for the specific 
staging of G1 or S/G2 cells using a flouresent proteins fused to CDT1 and Geminin [152]. This 
system has its limitations with the fluorescent proteins having excitation/emission overlaps with 
common secondary antibodies used for DNA damage foci analysis. Extensive molecular biology 
techniques would have to implemented to switch the fluorescent proteins in the Fucci system to 
ones that would be amenable to co- fluorescent studies. Another confounding issue is the N-
terminal domain of Cdt1, used by the Focci system, forms strong interactions with PCNA and 
participates in the DNA damage respose [153, 154]. Further studies would need to be carried out 
to determine if overexpression of Cdt1 or Geminin can alter DNA repair pathways.  
 The use of flow-cytometry with DNA dyes, and flourforescent markers specific for DNA 
damage factors could be utilized for cell cycle staging, but lack the spacial resolution necessary 
for the identification of DNA damage foci. Recently a new method for staging cell cycle of cells 
using a microscopy techiniqe was described [155]. In this technique the authors attempt to 
overcome many of the limitations mentioined above using a high resolution microscopy in 
conjuction with DNA dyes to accuarately stage the cell cycle. 
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 Here we present MANA, an image analysis pipeline that uses deep learning neural 
network and advanced image processing algorithms to analyze cell cycle and nuclear focal 
events using high-resolution confocal microscopy images. Our method allows for the analysis of 
asynchronous cell populations with high-resolution nuclear special information (Figure 4.1). 
 
Materials and Methods 
 
Cell Culture 
 Wild type HEK293T cells were maintained in 10% FBS, DMEM, Pen/Strep in 37 oC, 5% 
CO2.  
Microscopy 
 Microscopy images were collected on a Nikon TE2000 Inverted microscope with a 40X 
objective, 0.6 NA. 
Immunofluorescence 
 HEK293T cells were plated into 24 well dishes containing L-Poly lysine (75 000 -150 
000 MW) treated round cover slips. Cells were exposed to 10 Gy ionizing radiation and fixed at 
30 min, 60 min, 90 min, 180 min, 360 minutes and 720 minutes post irradiation with 4% 
Paraformaldhyde for 30 minutes at room temperature. Cells were washed with 200mM 
Glycine/1X DPBS for 10 min, permeabilized with 0.2%TritonX100/1XDPBS for 30min, 
blocked with 1% BSA/1X DPBS for 60 min. 53BP1 and BRCA1 were visualized by staining 
with primary antibody 53BP1 (1:500) and BRCA1 (1:1000) for 1 hr, followed by secondary 
antibody AlexFluor 488 (#A-11034, ThermoFisher Scientific) and AlexFluor 594 (#A-11032, 
ThermoFisher Scientific) at (1:2500) for 2 hours. Cells were washed with 1X DPBS/Hoechst 
























 Our implementation of MANA relies on the Mathematica programing language. 
Mathematica was chosen because of its robust and integrated machine learning and image 
analysis algorithms that facilitate a homogenous software development environment without the 
need for prior knowledge of multiple programing languages. It also allows for the generation of 
graphical user interface that facilitates the dissemination of MANA to individuals with no 
computer programing language experience. 
 MANA relies heavily on its ability to determine what constitutes a nucleus in an image. 
Image segmentation algorithms are used to isolate objects within the images, and a deep learning  
neural network is used to classify the objects as either nuclei or non-nuclei. Image segmentation 
relies on an algorithm that determines the local binary threshold values between the foreground 
and background in an image.  
 We developed an image segmentation pipeline that relies on local binary threshold rather 
than a global threshold algorithm to identify individual cells (Figure 4.2). Local thresholding 
allows for resolving of edges in images where objects are closely spaced, and is superior to 
global thresholding where a single threshold is picked for the entire image. The application of a 
global threshold results in erosion of nuclei due to uneven illumination across the image using a 
local adaptive binarization technique that allows for the capture of nuclei edges more robustly 
(Figure 4.3, Figure 4.4d). 
 We compared a local thresholding algorithm to a global thresholding algorithm in our 
segmentation pipeline. Both local and global algorithms can identify a similar number of objects 
and locations (Figure 4.4a,b,c). However, global thresholding results in the erosion of borders of 
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nuclei (Figure 4.4d). In order to maximize the area of nuclei recovered we utilized a local binary 
thresholding algorithm for the segmentation pipeline. 
 Having determined the optimal settings for image segmentation, we built a training 
database of objects curated from microscopy images in order to train a deep neural network to 
classify objects into “nuclei” or “non-nuclei”. To expand the image training data set, human 
identified nuclei and non-nuclei were subjected to a two degree shift in orientation to generate a 
new training set of 189,360 images (Figure 4.5). The training set was randomly sampled to 
generate a sub list of 120,000 images that was used to train a deep neural network (Figure 4.5). 
The network achieved 99.55% accuracy with less than 120 minutes of training (Figure 4.5).  
 MANA can process single plane images as well as images from a z-stack.  
A z-stack represents multiple optical slices through an object that allow for more precise 
observation of nuclear localization events. However z-stacking introduces optical artifacts 
caused by the recording of multiple diffraction patterns from multiple point sources of light. The 
point source emits light over a wide area, as a result a point light source will balloon in diameter 
as the focal plane moves farther from the source in either the positive or negative z direction. To 
compensate for this, images were deconvoluted. Deconvolution is a technique that removes 
artifacts by applying a point spread function to the image. Typically, this is done using a 
theoretical point spread function, however, each microscope has its own unique point spread 
function as a result of minute differences in optical paths. Therefore, we designed MANA to 
incorporate an experimental point spread function. 
 We experimentally determined the point spread function for our microscope system using 
two methods: first was a bead based method, and second was a search of our images for a point 
source of light. For our first method we used 3.0-3.5 µm rainbow beads designed for flow 
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cytometry laser calibration. The diameter of the beads was too wide for calculating the point 
spread function, however the sizes of the beads is not uniform and many sub-micron diameter 
beads exist, and we used these for a point source for FITC and TRITC channels (Figure 4.6a). 
The fluorescence in the DAPI channel was extremely weak and the beads could not be used for 
this channel. Therefore we implemented our second approach and scanned our nuclei images for 
sub-micron point sources of light in the DAPI channel (Figure 4.6a). We isolated the point 
sources of light for the TRITC, FITC, and DAPI channels and subjected them to circular 
symmetry processing to generate a diffraction pattern for each channel (Figure 4.6b). Image 
representations of the point spread function for each channel were generated by taking the 
maximum value in the y direction of each z stack image after circular symmetry processing 
(Figure 4.6c).  
 We applied the Richardson-Lucy deconvolution algorithm using the experimental point 
spread function for each channel in the z-stack [156, 157]. Deconvolution is computationally 
intensive, therefore deconvolution is only applied to isolated nuclei rather than the whole image. 
Figure 4.7, 4.8, 4.9 demonstrates the before and after images of deconvolution to a single nuclei 
for the DAPI, FITC and TRITC channels. The deconvoluted z-stack images are combined to 
generate a 3D representation of the nucleus (Figure 4.10a). Using an image segmentation 
technique that separates foreground pixels from background pixels identifies bright spots in in 
the FITC and TRITC channels (Figure 4.10b). The coordinates for nuclei foci are extracted and 
plotted onto graph for better visualization, and quantification (Figure 4.11).  
 Next, we performed a cell cycle staging into MANA. The fluorescence intensity of 
nuclear dyes such as Hoechst are directly linked to the amount of DNA present in the nucleus. 
Therefore it is possible to segregate nuclei into different groups, with 2N to 4N amount of DNA. 
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We designed a robust method to quantify DNA dye intensity using optical sections from a z-
stack.  
 First, the 3D nuclei image is converted to a plot representation of the image and then 
converted to a mass distribution representation of the image (Figure 4.12a,b). The mass 
distribution representation allows for the calculation of the center of mass, moment of inertia, 
and principle axes (Figure 4.12c). The degree difference between the principle axes and the xyz 
plane of zero rotation is used to calculate the rotational angle needed to rotate the nucleus such 
that the principle axes is perpendicular to the x axis (Figure 4.12d,e). We then collect pixel 
intensity values by applying a scanning window across the nucleus (Figure 4.13a). The area 
under the curve is calculated for each sliding window to generate an intensity profile (Figure 
4.13b).  
 From the intensity profile of each nuclei we calculate the area under the curve and plot it 
verses the maximum intensity value to generate a scatter plot that can separate nuclei into 
distinct clusters (Figure 4.14a). To determine which intensities correspond to phases of the cell 
cycle we implemented the Watson method for cell cycle peak calling [158, 159].  
 We applied MANA to quantify DNA damage repair foci formation and cell cycle staging 
HEK293T cells that were treated with 10Gy of ionizing radiation. We analyzed the cell cycle of 
cells 30 minutes, 60 minutes, and 720 minutes post irradiation exposure. MANA provides similar 
cell cycle staging as that has been reported for H3K293T cells exposed to ionizing radiation 
(Figure 4.14) [160]. We did observe lower than expected G2/M percentages. This is a technical 
issue with cell handling for HEK293T cells and not a limitation of MANA. G2/M phase 
HEK293T cells are easily removed from plates with little agitation. Therefor, it is necessary to 
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handle cultures carefully during sample preparation. Our experiments with embryonic mouse 
fibroblast yielded better results with respect to G2/M population representation (data not shown). 
  The most powerful aspect of MANA is its capability to incorporate high-resolution 
nuclear foci information for each cell in each phase of the cell cycle (Figure 4.15,16,17). This 
allows for precise measurements of spetial and temporal nuclear events in high resolution. The 
benefit for incorporating high-resolution microscopy into cell cycle data is it allows for the 
proper identification of nuclear foci. Widely used flow cytometers are incapable of 
distinguishing diffuse from punctate staining. Diffuse staining patterns of dyes and markers 
within nuclei is a common problem and can lead to misinterpretation of biological significance 
of staining. MANA can process high-resolution microscopy images in a high-throughput 
autonomous fashion allowing for the design and implementation of experiments that would 
otherwise be time prohibitive and impossible to control for user bias analysis.  
Discussion 
 We applied MANA to measure cell cycle kinetics and DNA damage foci. The use of 
MANA is not limited to only DNA damage foci. Any cellular event that leads to the coalescence 
of proteins, for which antibodies exist, can be analyzed by MANA. This technology allows for 
the high throughput analysis of high resolution microscopy images in a nearly machine 
autonomous fashion. As deep learning methodology improves and computers become faster we 
predict that the wide spread adoption deep learning neural networks in a wide variety of 
experimental data analysis will become commonplace. Areas of research that rely on microcopy 













Figure 4.1: MANA pipeline overview. A. High resolution microscopy images are (B) image 
segmented to isolate objects (C) and these objects are analyzes by a deep learning neural network 











Figure 4.2: Image segmentation using local binarization. The images displayed in the top row 
are the results of segmentation of nuclei using a thresholding algorithm that acts locally. The 
images on the bottom row are the results of segmentation of nuclei using a global thresholding 
algorithm. The sequential output of the segmentation pipeline is left to right. 
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Figure 4.3: Comparison of local and global binary threshold algorithms. (Top, from left to 
right) Local binary threshold with various settings that demonstrate the ability to resolve closely 
spaced object without erosion. (Bottom, from left to right) Global binary threshold with various 










Figure 4.4: Object identification using local and global threshold algorithms. A. Number of 
objects identified by local thresholding at various settings. B. Number of object identified by 
global thresholding at various settings. C. (Red) local threshold object, (Green) global threshold 











Figure 4.5: Deep neural network training for nuclei identification. Segmentation analysis 
allows for the isolation of objects that could be classified as nuclei or non nuclei. A human 
curated list of nuclei and non nuclei was expanded using a degree shift procedure in which each 
object was rotated 2 degrees. The final data set contains over 180,000 nuclei and non nuclei 








Figure 4.6: Experimental point spread function calculation. A. Point sources of light were 
isolated from images using TRITC, FITC, and DAPI channels. B. Isolated images from the z-
stack each channel were subjected to a circular normalization. C. Image representation of the 









Figure 4.7: Deconvolution of the DAPI channel nuclei. A. A representative nucleus from each 
z-stack image prior to deconvolution. B. Nucleus from (A) with Richard-Lucy deconvolution 








Figure 4.8: Deconvolution of the FITC channel nuclei. A. A representative nucleus from each 
z-stack image prior to deconvolution. B. Nucleus from (A) with Richard-Lucy deconvolution 








Figure 4.9: Deconvolution of the TRITC channel nuclei. A. A representative nucleus from 
each z-stack image prior to deconvolution. B. Nucleus from (A) with Richard-Lucy 











Figure 4.10: Three dimensional reconstructions. A. 3D reconstruction of the DAPI, FITC, and 









Figure 4.11: Quantification of Foci. Graphic representation of FITC (green dots) and TRITC 
(red dots) foci identified. Co localized foci are considered within two pixels of each other.  






Figure 4.12: Normalization of nuclei orientation. A. 3D graphical plot of a nucleus. B. Mass 
distribution plot of nucleus in A. B. Red axes represent the moment of inertia (principle axes). D. 
The nuclei is rotated about the principle axes such that it is perpendicular to the x-axis. E. The 








Figure 4.13: 3D volume scanning for intensity profile. A. 3D volume rendering showing a 
nucleus (Blue). The scanning window (Red) moves across the nuclei collecting intensity values. 










Figure 4.14: Cell cycle quantification using MANA. Cell cycle quantification of wild-type 
HEK293T cells analyzed 30, 60, and 720 minutes post exposure to 10 Gy ionizing radiation. The 










Figure 4.15: 53BP1 foci quantification and cell cycle staging. Scatter plots of wild type 
HEK293T cells co-stained with a DNA dye (Blue dots) and 53BP1 antibody (Red dots). The x-
axis is the area under of the DNA dye intensity profile and the y-axis is the maximum intensity 
profile of the DNA stain. An example of an intensity profile for Hoechst staining is in Figure 
4.13. The bounding regions for cell cycle phases were determined using the Watson method 










Figure 4.16: BRCA1 foci quantification and cell cycle staging. Scatter plots of wild type 
HEK293T cells co-stained with a DNA dye (Blue dots) and BRCA1 antibody (Red dots). The x-
axis is the area under of the DNA dye intensity profile and the y-axis is the maximum intensity 
profile of the DNA stain. An example of an intensity profile for Hoechst staining is in Figure 
4.13. The bounding regions for cell cycle phases were determined using the Watson method 










Figure 4.17: 53BP1/BRCA1 co-localization and cell cycle staging. Scatter plots of wild type 
HEK293T cells co-stained with a DNA dye (Blue dots) and 53BP1/BRCA1 antibodies (Red 
dots). The x-axis is the area under of the DNA dye intensity profile and the y-axis is the 
maximum intensity profile of the DNA stain. An example of an intensity profile for Hoechst 
staining is in Figure 4.13. The bounding regions for cell cycle phases were determined using the 




Chapter V: Histone Variant H2AZ Exchange at Sites Of Double Strand Breaks Requires 
Dot1l And H3k79 Methylation 
Abstract 
In the presence of DNA damage, the use of DNA repair pathways maintains genome integrity. In 
eukaryotic cells, the homologous recombination (HR) and non-homologous end joining (NHEJ) 
pathways are required for the repair of DNA double strand breaks (DSBs). The utilization of HR 
or NHEJ at the sites of DSBs is influenced by the local chromatin state. In mammals, histone 
modification and histone variant exchange at DSB sites generate an open chromatin state 
necessary for DSB repair to take place. How histone modifications contribute to histone variant 
exchange at DSB sites and how this processes contributes to DNA repair remains an important 
issue. In eukaryotes, phosphorylation of the histone variant H2A.X, termed γH2A.X, is an early 
histone modification that contributes to sensing DSBs. The propagation of the γH2A.X 
surrounding the break site leads to the recruitment of the p400/Tip60 containing NuA4 
remolding complex via MDC1[137, 161]. p400 catalyzes the exchange of H2A for H2AZ variant 
leading to histone acetylation and ubiquitination at the DSB site[136]. Histone exchange and 
modifications at the DSB site transitions the chromatin into an open state that is permissive for 
HR repair. Here we show that Disruptor of telomeric siliencing-1 Like (DOT1L) is required for 
H2AZ exchange at DSB sites. DOT1L and its homologue in yeast, Dot1, are the only histone 3 
lysine 79 (H3K79) methyltransferase in eukaryotic cells responsible for deposition of mono, di 
and tri methyl marks [101-103]. Cells from Dot1L-/- mice have increased genomic instability and 
defects in DNA repair. Loss of DOT1L and its methylation activity resulted in decreased H2AZ 
incorporation at DSB sites, increased amounts of single strand DNA (ssDNA) and decreased HR 
repair activity. We hypothesize that DOT1L and H3K79 methylation marks facilitate histone 
exchange at DSB sites generating a chromatin state that is permissive for HR repair. In the 
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absence of either DOT1L or H3K79 methylation the NHEJ repair pathway is utilized leading to 
genomic instability.   
Material And Methods 
Dot1L Knockout mice 
 Dot1L mutant mice were generated as described [162]. 
Ex vivo erythroid differentiation assay 
 Cells from E10.5 Dot1L-/- and wild-type yolk sacs cultured in M3434 methylcellulose 
medium (StemCell Technologies) containing the cytokines SCF, IL-3, IL-6, and EPO, which 
promote the growth of erythroid and myeloid progenitors.  
Cell Culture and Cas9 Targeting 
 Embryonic day 10.5 (E10.5) embryos were obtained from timed matings between 
heterozygous Dot1L mutant mice, mouse embryonic fibroblasts (MEF) were isolated and 
cultured in DMEM, high glucose, L-glutamate, Sodium Pyruvate (Life Technologies, 11995-
040), 10% fetal bovine serum (Life Technologies 10082-147), supplemented with 20 mM 
HEPES (Life Technologies 15630-080), L-glutamte, and Non-essential amino acids. HEK293T 
cells were cultured in DMEM, high glucose and 10% fetal bovine serum. DOT1LStop and 
DOT1LY312A cell lines were generated by Cas9/ssDNA directed cleavage/repair. PX330 plasmid 
(Zhang lab) was modified to express an eGFP-P2A-Cas9 gene (PXeC) and a gRNA targeting 
amino acid 312 of DOT1L. A 150 nt single stranded oligonucleotide, antisense to transcription, 
was used to direct repair of the Cas9 cleaved locus by destroying the PAM, adding a DdeI 
restriction site and either adding three tandem stop codons or nucleotides converting Tyrosine 
312 to Alanine. HEK293T cells were transfected with a 1:1 molar ratio of PXeC and ssDNA 
using Effectine (Qaigen) in a six well dish. Cells were sorted for eGFP expression 48 hrs after 
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transfection (FACSaria II, BD). Colonies were picked 5 days later, genomic DNA was extracted 
and a PCR/restriction digest with DdeI was used to initially identify DOT1L KO and Y312A 
positive clones. Western blot and Sanger sequencing was used to verify clones.  
Immunofluorescence 
 E10.5 MEF were plated into 24 well dishes containing L-Poly lysine (75 000 -150 000 
MW) treated round cover slips. For end resection assay Cells were grown in conditioned media 
(1:2) for 48 hrs prior to Brdu addition. Cells were cultured in 10µM BrdU for 48hrs and exposed 
to ionizing radiation. Cells were fixed at 15 min, 30min, 60min, 120min and 240min post 
irradiation with 4% Paraformaldhyde for 30 min at room temperature, cells were washed with 
200mM Glycine/1XDPBS for 10 min, permeabilized with 0.2%TritonX100/1XDPBS for 30min, 
blocked with 1%BSA/1XDPBS for 60 min. For BrdU incorporation positive control cells were 
treated after Glycine wash with ice cold 1N HCl for 20min, 2N HCl for 10 min, neutralized with 
room temperature phosphate buffer, pH7.4 for 10 min, flowed with permeablization, and 
blocking as above. BrdU was visualized by staining with primary antibody MoBu-1 (1:500) for 1 
hr, followed by secondary antibody AlexFlour 588 (1:1000) for 2 hrs.  
Western Antibodies and immunefluorescence  
 H3K79 di meth (ab3594), H3K79 mono meth (ab2886), H3 (ab1791), RAD51 (ab63801), 
53BP1(ab36823), BRCA1,( ab16780), H2AZ (#2718, CellSignaling), H4K acetylation (ab7311). 
qPCR and DNA damage pathway primers 
 qPCR was performed using Power SYBR® Green PCR Master Mix (#4367659, 
Thermofisher Scientific), primers with annealing temperature of 61oC and 40 cycles on ABI 
7900 system. Two-tailed Student’s t-test was used for significance testing. Primers for mouse 
DNA damage pathway genes were designed using IDT PrimerQuest Tool. Total RNA was 
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isolated from cells of E10.5 Dot1L-/- and wild-type mice that were 6 hours post ionizing radiation 
treatment (2 Gy). 
Gene Fwd Rev 
Anxa5 CGAATAGAGACCCTGATACTGC ACTGCGTGTCCCAAAGATG 
Atm GATCCTTCCCACTCCAGAAAC ACTCCGCATAACTTCCATCG 
Atr TCCTGAAAATAAGTCCCCATCTG TGGCAGAAACAAGGTCACATC 
Atrip CTTCTCCTGAGGCTGTACATG ACAGTCAGAACCAATGCCAG 
Bard1 TCCCGCTGTGCTAATATTCTG GTCGGTTTATCTTGAGGTCTAGG 
Blm TGGATCAGAAAGCATCACCC GTAAAGTGTCAGCCATTGTGTC 
Brca1 AGGGAAGCACAAGGTTTAGTC CCTCATTCAAACGCTCACAAG 
Brca2 CTTTAGAGCCGGTTACCTGTG AGGACTGCTTGGAGACTTTTC 
Cdk1 TGCAGGACTACAAGAACACC GCCATTTTGCCAGAGATTCG 
Cdk2 GCATTCCTCTTCCCCTCATC GGACCCCTCTGCATTGATAAG 
Chd1l TCTCTGTCCCTTGTCTGTTTTG ACGTGAAAACCTGACTCCTG 
Chek1 ACTGGTTGACTTCCGACTTTC ACAGCTTCCTCATGTAACAGG 
Chek2 CTGAGGACCAAGAACCTGAAG CCATCGAAGCAATATTCACAGC 
Dclre1c TCGTGTGGCTGAACTGTAAAG TTCTGTCCGTTGTGAGATGG 
Eme1 TGGTAGAGGATGGAGATGACTG AGTTACAAAGCTCCGAAGGG 
Ercc1 CCCGTGTTGAAGTTTGTGC CCGTTCATGGATGTAGTCTGG 
Ercc4 CAGACGGCCATACTAGACATC CCACAAAGGGTCCAAGTAATG 
Exo1 CAGTAGGGATTCAGGTTCAGAG ACTAGACCTACAGAGCCCAG 
Gen1 TGCCGTTGATTTGAGTCTCTG TCCCCTTCCATTACAAACACC 
H2afx AAGTCGCGCTCTTCACG TCTCGGCAGTGAGGTACTC 
H2afz GTATCACCCCTCGTCACTTG TCTTCTGTTGTCCTTTCTTCCC 
Herc2 ACACCAGGCATACTTTCGG GTTCAGGCTTTTCACCATTCG 
Kat5 CACATCGTGGGCTACTTCTC GGTCTTCCCTTCTACTTTCGAG 
Lig3 AGTGGGAATGAAGAGGAAAGC GTGTAGAAGGTGGCAAGTAGAG 
Lig4 CCCCTGTGATTGCTGACTTAG TCTCGTGGCTTCAATTCTGG 
Mdc1 TGATTGACTGGGATGCTGAAG CATTCTTGCCAAGGTAGAGGG 
Mre11a CAGAAAGGAAGCACAAAACTCG TCACAAACATCCGATAGAGCC 
Mus81 GATATTAAGGAGTCGGCTGGC GAGAGGGTTTGTGGAAGGC 
Nbn CCTTTCCCAAGTCCTGTCAG CAGCCCAGGGATCTTTACTTC 
Nhej1 GTTATGCCTTGCTGATTTCGG ATCCAGGTGACAGAGCAAAG 
Palb2 AACCCAGGAAACCTACAGTTG AGCAGTTACGATACATGGCTC 
Parg GATTGTTTCACGGCTGTTCAC ATCGTCCTTTTCACTCCCATC 
Parp1 CAGCGAGAGTATTCCCAAGG AAGCCATCCACCTCAACATC 
Pias4 CCTTACCCACCTCATGTATCTG TCACCCCAATCGTCTTCAAC 
Prkdc TTCTCCATACCCAAACCCAAG CTCCCAGTCAGCCAATCAAA 
Rad50 AGTGTGCCTGACAGATGTTAC GCTTTTCCTGCTTTTCCTGG 
Rad51 TGGTGTCGCAGTGGTAATC CTCCCCTCTTCCTTTTCTCAG 
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Rad52 CCAGCATGTTCTAGGTAGCAG TCCTTTTGTGACGGTCTAGTG 
Rbbp8 CCAAGCAACCAAGATACGTCC TCCATGTCCACTGTTTCTCC 
Rmi1 GATCCTACAGTTCCAGTCATTCC GCCCCAAAACAGCATCTAAG 
Rmi2 TCCAGAAAATCAGATCCAGTCAC CAGATGTCTTCCTCAAGCTCAG 
Rnf168 TGAACGACTTGCTGGAGAAC TTCGACAAATGGGACACTCTAC 
Rnf8 ACGTTCAGAATCAGGGTCAAG GGTACTTGCTCCCATCACATG 
Rpa1 GTCTTGTCCTTTATCAGTTGTGC CAATTTCCGAGATGCCAGTTTC 
Slx1b GGAAGAGGATTTGGAGTTAGAGG GAGAAGCAGGAAAGGTACAGG 
Slx4 CTGAACTACCTCTACATGGCAG TCTGGCTGTTCTCCCTCTAAG 
Top3a GTCTTGTCCTTTATCAGTTGTGC CAATTTCCGAGATGCCAGTTTC 
Trp53 ATGTTCCGGGAGCTGAATG CCCCACTTTCTTGACCATTG 
Trp53bp1 CCCTGATGCTTTCCGATCTAC TCTGTCTCCATTGCTTCGTC 
Ube2i GAACCAAATATTCAAGACCCAGC CAATCCCTTCCTCGTCATGG 
Ube2n TGATGTAGCCGAGCAATGG TTGGCAGAACAGGAGAAGTG 
Uimc1 TGATGGAGCAGGAAACAGTG GTGGAACCAGGGACTTACATAG 
Usp28 GTGACATTACCACTTCCCTCG CATTCATCCCCTCAGAGCTG 
Xrcc1 GCTGGGACCGTGTTAAAATTG GTCACTGTCACCTTCTGAGATG 
Xrcc4 TGGGACAGAACCTAAAATGGC GGGTAGTGAAGAGGCAAGC 
Xrcc5 TGACTGCTCAGGACGTTTTC CCTTGGTGATGTTCCCTTCTG 
Xrcc6 CGGGAAACAAATGAACCAGTG TCCTCTTTCTCCAGCACAATC 
Table 5.1: qPCR primers for DNA damage repair pathway genes in mice. 
ssDNA assay 
 ssDNA was measured using a method designed to enrich for ssDNA and sequenced on an 
Oxford Nanopore MinION. The methodology is described in Chapter III. 
BEL-Chip 
 BEL-ChIP was performed on wild-type, DOT1LStop and DOT1LY312A cell lines using 
H2AZ (#2718, CellSignaling), H4K acetylation (#ab7311, Abcam) antibodies. BEL-ChIP is 
described in Chapter II. 
Cell cycle staging and foci analysis 
 Cell cycle staging and foci quantification were performed on cells isolated from E10.5 
Dot1L-/- and wild-type mice using MANA. Cell cycle staging and foci quantification were 
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performed on wild-type, DOT1LStop and DOT1LY312A cell lines using MANA. MANA is 
described in Chapter IV. 
HR/NHEJ assays 
 Wild-type, DOT1LStop and DOT1LY312A HEK293T cell lines expressing an HR reporter 
[163], alt-NHEJ reporter [69], and a NHEJ reporter [69], were transfected individually with 
Effectine (Qiagen) and selected for using puromycin. Five days post-transfection, cells were 
transfected with the I-SceI plasmid using Effectine (Qiagen), and GFP-positive cells were 
counted 48 hr later using a Invitrogen Attune. 
Nucleosome stability assay 
 The nucleosome stability is described in [144].  Wild-type, DOT1LStop and DOT1LY312A 
cell lines were exposed to 10 Gy ionizing radiation and harvested at 30, 60, and 240 minutes post 
IR. Cells were washed with ice-cold PBS and re-suspended in 500 µL of Stability buffer (20 mM 
Hepes, pH 7.9, 0.5 mM DTT, 1.5 mM MgCl 2, 0.1% Triton) containing 1.0 M NaCl, Roche 
Protease Inhibitor cocktail) and agitated constantly for 40 min at 4 °C. Cells were collected by 
centrifugation at 100,000 × g (Beckmann Ultracentrifuge) for 20 min, and the supernatant was 
analyzed by western blot. 
Comet assay and analysis 
 The neutral comet assay was performed using the Trevigen Comet Assay kit (Trevigen, 
Gaithersburg, MD). Cells were isolated from yolk sacs of E10.5 Dot1L-/- and wild-type mice 
grown ex vivo differentiation media (see above), after 4 days cells were harvested and 
resuspended in cold PBS, and an aliquot of cells (1000/10 µl) was added to 100 µl of molten 
LMA agarose and spread onto a comet slide. The slide was incubated at 4 °C for 10 min to and 
transferred to cold lysis solution for 60 min at 4 °C. A denaturation step was performed in 50 
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mM Tris base, 150 mM pH 9, for 30 min at 4 °C. The slides were then subjected to 
electrophoresis with cold TAE buffer, pH 8.2 at 25 V for 30 min at 4 °C, and immersed in DNA 
precipitation solution (100 mM NH4Ac in 95% ethanol) and then in 100% ethanol for 30 min 
and air dried. DNA was stained with 100 µl SYBR Gold (Invitrogen, 1:30,000) for 20 min and 
immediately rinsed with dH2O and air-dried. The slides were imaged using an upright Nikon 
Eclipse 80i fluorescence microscope at ×20, and analyzed using CometScore Pro (TriTek Corp). 
  For the repair of induced DNA damage assay cells were isolated from E10.5 Dot1L-/- and 
wild-type mice and exposed to 2 Gy of ionizing radiation and a comet assay was performed as 
above at 24, 72, and 96 hours post exposure. Comets were analyzed using a custom comet 
analysis software development in Mathematic programing language; the code for CometTool is 
provided below.  

















Introduction and results 
 We previously generated Dot1L knockout (Dot1L-/- ) mice to study the function of Dot1L 
during embryogenesis. A majority of Dot1L-/- mice die at embryonic day 10.5 (E10.5) with 
defects in erythroid progenitor development, G1/G0 arrest, and increased apoptosis when treated 
with erythroid growth factors [162]. The anemic phenotype in Dot1L -/- mice is hypothesized to 
be a result of the loss of an erythroid specific transcriptional program [106, 107, 162, 164-167]. 
However, an accumulating body of work indicates that Dot1L plays a role in genome integrity 
and DNA repair[112-116, 126, 127]. Thus, we propose an alternative hypothesis: the loss of 
erythroid lineage cells in Dot1L-/- mice is a function of its role in DNA repair. Hematopoietic 
stem cells (HSC) accumulate DNA damage overtime through the generation of reactive oxygen 
species (ROS) [168, 169]. The in vivo cytokine-induced mobilization of quiescent HSCs forces 
their entry into the cell cycle and forces a switch from the NHEJ to the HR repair pathway [170]. 
Our previous work demonstrated that E10.5 Dot1L-/- mice have similar numbers of 
hematopoietic progenitors as wild-type littermates, however, cytokine-induced differentiation 
promoted apoptosis [162]. Several reports indicate that compromised DNA repair pathways 
decrease the ability of HSC to self-renew and differentiate [171-174]. To interrogate whether 
hematopoietic progenitors derived from Dot1L-/- mice accumulate DNA damage, cells from 
E10.5 yolk sacs were cultured in media containing the cytokines SCF, IL-3, IL-6, and EPO, 
which promote the growth of erythroid and myeloid progenitors. After 4 days of growth, we 
harvested the cells and analyzed endogenous DNA damage. Utilizing an alkaline comet assay, 
we observed increased DNA DSBs and single-strand breaks (SSB) in Dot1L-/- hematopoietic 
progenitors when compared to wild-type littermates (Figure 5.1). The observation that Dot1L-/- 
embryos are anemic is the most noticeable phenotype; however, upon closer inspection the extra-
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embryonic vasculature of the yolk sac contains drastic alterations [162, 175]. Disrupted 
architecture of the HSC niche in the yolk sac of Dot1L-/- embryos could contribute to their 
anemic phenotype [176]. Therefore, we tested if alternations in proliferation and DNA damage 
were limited only to the hematopoietic linage.  
 Our previous work demonstrated that cells isolated from Dot1L-/- yolk sacs have a G1/G0 
arrest when stimulated with growth cytokines [162]. We tested if cells isolated from the embryo 
proper of E10.5 Dot1L-/- mice had similar cell cycle delay using a microscopy cell cycle analysis 
method (MANA, Chapter IV) [155]. We compared the overall proportion of Dot1L-/- and wild-
type cells in each phase of the cell cycle and observed more Dot1L-/- cells in the G1/G0 phase 
and fewer cells in the G2/M phase (Figure 5.2a). The G1/G0 accumulation is similar to our 
previous results for Dot1L -/- erythroid differentiation culture [162]. We also observed that 
Dot1L-/- cells proliferate at slower rates than wild-type cells, and stop dividing after three 
passages (Figure 5.2b). We corroborated the proliferation defects using a microscopy based 
BrdU incorporation assay, in which we pulsed cells isolated from E10.5 Dot1L-/- embryos for 24 
hours . Cells from Dot1L-/- embryos showed less BrdU positivity when compared to wild-type 
littermates four days after isolation (Figure 5.3). Based on these results, we generated two 
hypothesis: first, there exists a bona fide G1/G0 arrest in Dot1L-/- embryonic cells thereby 
limiting the pool of cells that are able enter S/G2/M phases; second, a subset of Dot1L-/- cells fail 
to exit S/G2/M properly and never renter the cell cycle. If cell loss occurs in S/G2/M phase, it 
would appear as though a G1/G0 arrest was occurring as the proportion of cells remaining 
inflates the G1/G0 peak.  
Implementation of MANA relies on training a deep learning neural network for nuclei 
identification (see Chapter IV). Human curated nuclei images were used as training data for the 
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network (see Chapter IV, Figure 4.5). We examined the output of the neural network used for 
MANA and found that abnormally shaped nuclei were excluded from the cell cycle analysis. 
Characterization and quantification of these nuclei reveled that cells isolated from E10.5 Dot1L-
/- embryos have increased abnormal nuclear boundaries with blebs, chromosomal bridges, and 
mitotic catastrophes (Figure 5.4a) [177]. This data supports the hypothesis that the decrease in 
G2/M phase population is a result of incomplete G2/M exit. During our assessment of the 
MANA neural network output we also observed that nuclei from Dot1L-/- embryos contain 
increases in micronuclei abundance, a marker of genomic instability (Figure 5.4b)[178, 179]. 
Replicative stress is hypothesized to be a source for micronuclei formation, and bypassing the 
intra-S-phase check point can lead to the accumulation of chromosomal breaks and abnormalities 
[178, 180]. It has been reported that the yeast mutant strain, ΔDot1,  has a defective S-phase 
check point [113]. It is conceivable that cells from E10.5 Dot1L-/- embryos accumulate DNA 
damage during the S-phase that goes unrepaired resulting in a highly unstable genome and a loss 
of cells during G2/M.  
 We therefore tested if cells isolated from E10.5 Dot1L-/- embryos fail to repair DNA 
following genotoxic stress. We used low dose ionizing radiation (IR) to introduce DNA damage, 
and assayed for DNA repair using an alkaline comet assay. Cells isolated from E10.5 Dot1L-/- 
embryos and wild-type littermates have similar amounts of DSBs and SSB 24 hours post IR 
(Figure 5.5). However, 72 and 96 hours post IR cells from E10.5 Dot1L-/- embryos accumulate 
more DNA damage than wild-type cells (Figure 5.5). This indicates that after exposure to DNA 
damage E10.5 Dot1L -/- cells fail to completely repair DNA breaks. The persistence of unrepaired 
DNA damage can lead to genomic instability, cell cycle arrest, and apoptosis. To that end we 
tested if the presence of unrepaired DNA damage could lead to growth arrest. Using a 
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microscopy based BrdU incorporation assay we pulsed cells isolated from E10.5 embryos for 24 
hours and observed that 96 hours after IR treatment both Dot1L -/- and wild-type cells have 
decreased proliferation rates as compared to non-IR treated cells (Figure 5.6, Figure 5.3). 
Interestingly even though cells from E10.5 Dot1L-/- embryos have more DNA damage at 96 
hours post IR, proliferation persists, albeit at a slower rate (Figure 5.6). This observation 
suggests that cells from E10.5 Dot1L-/- still proliferate in the presence of large amounts of DNA 
damage, which we hypothesize is a mechanism for why they have increased endogenous DNA 
damage, as we observed in erythroid lineage cells isolated from Dot1L-/- mice (Figure 5.1).  
An accumulation of unrepaired DNA indicates that cells from Dot1L-/- embryos have 
defects in DNA damage repair (DDR) pathways. It has been hypothesized that Dot1L might have 
a roll in the recruitment of NHEJ repair factor 53BP1, however a mechanism for direct 
recruitment of DNA repair factors remains to be identified [115, 116, 126, 127]. Dot1L has 
primarily been studied for its role as a transcriptional activator and it is possible that the 
accumulation of DNA damage in cells isolated from Dot1L-/- embryos is a result of decreased 
expression of DDR genes [108]. We performed a comprehensive analysis of DDR pathway 
factors using cells isolated from E10.5 Dot1L-/- embryos and wild-type littermates. Cells isolated 
from E10.5 Dot1L-/- embryos have elevated expression of several factors involved in sensing 
DNA damage (Figure 5.7a).  
Chd1l is a factor known to interact wtih poly(ADP-ribose) (PAR), histones, and facilitate 
nucleosome remolding and DDR [181, 182]. Parp1 (PAR polymerase 1) is responsible for 
deposition of PAR at break sites and Parg is a glycohydrolase responsible for the removal of 
PAR preventing accumulation during prolonged replicative stress, both are necessary for DDR to 
take place [183, 184]. The histone variant H2afz (H2AZ) is exchanged in nucleosomes 
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surrounding the DSB sites and restricts the end resection machinery [136]. The upregulation of 
DNA damage sensors in cells isolated from E10.5 Dot1L-/- embryos suggests that transcripts 
necessary for sensing DNA damage are present. At the protein level, E10.5 Dot1L-/- embryonic 
cells form DDR foci for the DNA damage sensor γH2A.X after treatment with IR, indicating 
they are capable of sensing DSBs (Figure 5.8).  
We also observed that cells isolated from E10.5 Dot1L-/- embryos have increased 
expression of several transcripts necessary for HR repair (Figure 5.7b). Of note is the increase in 
expression of Brca2, Exo1, Rbbp8, Rmi1, Top3a, Blm, Slx4, Slx1b, and Gen1. Brca2 interacts 
with ssDNA and facilitates the loading of Rad51 onto ssDNA following DNA damage [185]. 
Exo1 is an endonuclease that responsible for long-range end resection events following DNA 
damage [186]. Rbbp8, (aka CtIP), is an endonuclease that is responsible for short-range end 
resection events following DNA damage [88]. Blm, Rmi1, and Top3a form a complex that 
enhance end resection through DNA helicase activity [187, 188]. Slx4, Slx1b, and Gen1 are 
involved in holiday junction resolution following DNA damage [189-191].  
We examined the ability of cells isolated from E10.5 Dot1L-/- embryos to form DDR foci 
for the HR factor Rad51 and we observed a delay in its accumulation following IR treatment 
compared to wild type littermates (Figure 5.9). The expression of Rad51 is reduced in wild-type 
cells isolated from E10.5 embryos after exposure to IR; however, this does not preclude the 
formation of DDR foci (Figure 5.7b, Figure 5.9). The expression of Rad51 in cells isolated from 
E10.5 Dot1L-/- embryos is at a similar level to wild-type littermates after exposure to IR (Figure 
5.7b). The reduction in transcript level for all genes analyzed following IR exposure (Figure 5.7) 
is not without precedent. It has been reported that RNA polymerase II is inhibited following 
DNA damage, leading to a reduction in transcript levels [192]. We also examined the expression 
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of other genes involved in the NHEJ and alternative NHEJ (alt-NHEJ) pathway (Figure 5.7c). 
Similar to the genes in the DNA damage sensing and HR repair pathways cells isolated from 
E10.5 Dot1L-/- embryos have elevated expression of NHEJ and alt-NHEJ pathway transcripts 
(Figure 5.7c).  
We observed the elevated expression of Lig4, Trp53bp1, Xrcc4, Lig3, and Rad52 (Figure 
5.7c). Classically considered a promoter of NHEJ, Trp53bp1 is thought to prevent Brca1/CtIP 
from loading onto breaks, thereby promoting NHEJ though Ku70/Ku80 binding [148]. However, 
recent work points to a role for Trp53bp1 in HR repair, whereby it prevents hyper end resection 
and single strand annealing (SSA) repair via Rad52 by promoting Rad51 assembly on ssDNA 
[77]. It is an intriguing correlation that Rad52 expression is elevated along with Exo1, another 
factor involved in hyper end resection and SSA repair (Fig 2d). The yeast mutant strain, Δdot1, 
has a hyper end resection phenotype [125]. We analyzed Trp53bp1 foci formation in cells 
isolated from E10.5 Dot1L-/- cells that were treated with IR (Figure 5.10). Surprisingly, and 
counter to previous reports, we did not observe a loss of Trp53bp1 foci following IR treatment 2 
hours post IR, indicating that some aspect of NHEJ repair pathway is intact. Our data indicate 
that cells from Dot1L-/- embryo can sense and respond to DNA damage, however, the response is 
altered with a delay in the formation of Rad51 damage following IR treatment (Figure 5.9). We 
hypothesize that the alteration in DDR repair factor recruitment can shift the balance of DDR 
pathway utilization. 
 Dot1L is the only reported H3K79 histone methyltransferase. The methyltransferase 
activity of Dot1L and regions of its C-terminus have been hypothesized to be involved in DNA 
repair [116, 126]. In our Dot1L-/- mouse model, expression from the Dot1L locus is ablated using 
a gene trap, thereby preventing us from separating Dot1L enzymatic activity from protein-
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protein interaction activity [162]. We sought to isolate the enzymatic function of Dot1L in DNA 
repair from other protein functions using a genetic approach. We utilized the CRISPR/Cas9 
system to generate two DOT1L mutant HEK293T cell lines; DOT1LStop and DOT1LY312A (Figure 
5.12, Figure 5.13) [193, 194]. We chose to target Y312A because it is a critical residue for 
methylation, and satisfied the CRISPR/Cas9 targeting constraints [195, 196]. We designed an 
eGFP-P2A-Cas9 construct to allow for transient expression and cell selection via FACS to avoid 
stable integration, and expression of the Cas9 construct (Figure 5.11a). We utilized a 150 
nucleotide single stranded oligonucleotide for homology directed repair to introduce nucleotide 
substitutions into the DOT1L locus that converted the nucleic acid sequence corresponding to 
amino acid Y312 to either three tandem stop codons or an alanine while simultaneously 
generating a ubiquitous restriction site DdeI used for screening (Figure 5.11b, Figure 5.12, 
Figure 5.13). Both DOT1LStop and DOT1LY312A results in loss of H3K79 di- and tri-methylation 
marks, while only DOT1LStop reduces DOT1L protein level (Figure 5.11b). We were surprised 
that HEK29T cells remained viable after targeting, as our work with primary mouse cells and 
other immortalized human cell lines (data not shown) led us to anticipate that reduction of 
DOT1L protein or inhibition of enzymatic activity would result in cell death.  
In DSB break repair two factors influence repair pathway utilization: the stage of the cell 
cycle in which the DSB occurs, and how quickly DNA damage repair factors assemble at the 
break site [71, 197, 198]. An initial step of DNA double strand break repair factor assembly 
begins with the MRN (Mre11-Rad50-Nbs1) complex sensing the break site, and phosphorylation 
and activation of ATM [199]. Activated ATM in turn phosphorylates the histone variant H2A.X 
at the site of the break and in concert with H2AZ, sets the boundary for the DNA damage repair 
machinery [136, 200]. The phosphorylation of H2A.X is required for the recruitment of MDC1 
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to site of the break [67]. MDC1 binding then leads to clearance of proteins surrounding the break 
site and, depending on the timing, either HR or NHEJ repair will be used [71]. For example, 
53BP1 can promote NHEJ at DNA breaks by out-competing the recruitment of HR repair factors 
such as BRCA1 [57, 71]. To gain insight into the mechanism of DOT1L effect on DDR factor 
loading, we studied the kinetics of 53BP1 and BRCA1 DNA damage foci formation (Figure 
5.14). We treated wild-type, DOT1LStop, and DOT1LY312A cells with IR and analyzed 53BP1 foci 
formation at different time points (Figure 5.14). We observed that DOT1LStop and DOT1LY312A 
cells have reduced 53BP1 foci compared to wild-type HEK293T cells starting at 30 minutes for 
DOT1LY312A and 60 minutes for DOT1LStop (Figure 5.14a). BRCA1 foci levels for DOT1LY312A 
are significantly less at 60 minutes post IR while little effect on BRCA1 foci is observed in 
DOT1LStop mutants (Figure 5.14b). We also observed that in DOT1LY312A mutants exposed to IR, 
BRCA1 is predominately localized to the cytoplasm, this could account for its reduction in DNA 
damage foci (data not shown). 53BP1 and BRCA1 are classically viewed as having a competing 
roll in DNA damage repair and work to limit each other at break sites [201]. However, recent 
studies have added evidence for 53BP1 working to facilitate HR by limiting end resection {Ochs, 
2016 #237. We compared the co-localization of 53BP1 and BRCA1 following IR treatment. We 
observed a decrease 53BP1/BRCA1 co-localization events in DOT1LStop and DOT1LY312A mutant 
cell lines at later times post IR. (Figure 5.14c). The alteration to 53BP1 and BRCA1foci 
formation and localization in DOT1L mutants could lead to alterations in repair pathway 
utilization.  
To gain functional insight into the observed foci kinetic differences in wild-type cells, 
DOT1LStop and DOT1LY312A HEK293T cells we utilized three different systems to monitor DDR 
pathway utilization: DR-GFP for HR, E5J-GFP, and E2J-GFP for NHEJ and alt-NHEJ 
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{Bennardo, 2008 #238;Pierce, 1999 #113}. We observed that 48 hours after introducing a break 
into the DR-GFP cassette, both DOT1LStop and DOT1LY312A have reduced levels of GFP positive 
cells indicating a loss of HR repair activity (Figure 5.15a). This result correlates with the delay in 
BRCA1 foci formation we observed in DOT1LStop and DOT1LY312A (Figure 5.14b). Next we 
examined NHEJ repair activity using wild-type, DOT1LStop, and DOT1LY312A cells lines stability 
expressing the E5J-GFP plasmid. We observed the DOT1LStop mutant could still process breaks 
using NHEJ, but interestingly there was a decrease in NHEJ repair in the DOT1LY312A mutant 
(Figure 5.15b). This suggests that at some level, NHEJ repair requires a DOT1L protein that is 
enzymatically active or it directly requires H3K79 methylation. Our DDR foci show that both in 
DOT1LStop and DOT1LY312A form 53BP1 foci similar to wild-type, but have altered BRCA1 foci 
formation kinetics. We hypothesize that the attenuation of BRCA1 foci formation and the loss of 
co-localization in DOT1LStop and DOT1LY312A leads to a favoring of NHEJ repair pathway. We 
also examined alt-NHEJ repair activity using wild-type, DOT1LStop, and DOT1LY312A cells lines 
stability expressing the E2J-GFP plasmid, which measures alt-NHEJ activity. We observed 
DOT1LStop had increased amounts alt-NHEJ activity compared to wild-type (Figure 5.15c). The 
increase in alt-NHEJ is consistent with our observations of upregulation of in NHEJ pathway 
components and end resection machinery in cells isolated from E10.5 Dot1L-/- embryos (Figure 
5.7b,c). Our data point to a mechanism whereby in the absence of DOT1L, cells utilize error 
prone DNA repair pathways.  
  We were interested in understanding how DOT1L and DOT1L mediated H3K79 
methylation activity might influence histone dynamics at DSB sites. DOT1L mediated H3K79me 
is a unique epigenetic mark as it occurs on the core of histone. It is hypothesized that H3K79me 
can influence the how tightly the histone octamer can associate with DNA because H3K79me 
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leads to open, relaxed chromatin and in its absence, the DNA is more tightly associated with 
histones. We wanted to test this hypothesis in the context of DNA damage-induced histone 
dynamics using a nucleosome stability assay. In this assay, we analyze histones that remain 
associated with a normalized about DNA following IR in the presence of high salt (Figure 5.16). 
Recent work has indicated that histone exchange of H2AZ at sites of DSB can influence DNA 
repair pathway choice [136]. Therefore, we tested the stability of H2AZ in the genome of wild-
type, and DOT1LStop and DOT1LY312A HEK293T cells (Figure 5.16a). We observed that 60 
minutes post IR, H2AZ is easily removed from DNA of wild-type HEK293T cells and is more 
stable in DOT1LStop and DOT1LY312A mutants. (Figure 5.16a). The stability of H2AZ in wild-type 
chromatin increases with time, and by 240 minutes post IR H2AZ reaches a plateau of stability 
(Figure 5.16a). The stability of H2AZ in DOT1LStop and DOT1LY312A mutants does not change at 
between –IR and up to 240 minutes post IR treatment (Figure 5.16a). This leads us to 
hypothesize that in DOT1LStop and DOT1LY312A mutants H2AZ is more stably associated with the 
DNA and is not easily removed following IR treatment.  
An epigenetic mark that has been associated with relaxed and open chromatin following 
DNA damage is H4 acetylation [144]. It is hypothesized that the exchange of H2AZ at the site of 
DNA breaks leads to a packed chromatin state and the subsequent removal of leads to H4 
acetylation, transitioning the chromatin into a more relaxed state permissive for HR repair [144]. 
Using a nucleosome stability assay, we measured the stability of H4 acetylated histones 
following IR treatment (Figure 5.16b). In wild-type, DOT1LStop and DOT1LY312A mutant 
HEK293T cells,  we observe a decrease in H4 acetylated histones following IR (Figure 5.16b). 
This result can be  two ways; first, H4 acetylated histones are associated with nucleosomes less 
stabl after IR, or second H4 is rapidly deacetylated following IR. We also analyzed H3 stability 
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following IR treatment and observed that in wild-type HEK293T cells, H3 is less stable 60 
minutes following IR treatment (Figure 5.16c). This suggests a general phenomenon that 
genome-wide stability of histones is altered in Dot1L deficient cells, perhaps allowing the 
histone exchange necessary for DSB repair to take place. It is of note that in DOT1LStop and 
DOT1LY312A mutants, H3 is more stable than in the wild-type cell line (Figure 5.16c). This 
observation suggests that in cells lacking a function DOT1L have histones that are more tightly 
pack and not easily removed. The histone dynamics measured by stability assays are only 
capable of global detection, and information about local histone dynamics around the break site 
are lost. To address this limitation we developed an assay that can monitor the histone dynamics 
at break sites: BeL-ChIP (broken end ligation ChIP) (Figure 17a, Chapter II for details). In this 
assay we ligated a hairpin adapter to broken ends of DNA following IR treatment, followed by a 
ChIP procedure, and ligated a second adapter following shearing of the genomic DNA. Only 
fragments that contain both adaptors were amplified, thereby allowing for identification histones 
present at the break site. We performed the BeL-ChIP on H2AZ 60 minutes post IR in wild-type, 
DOT1LStop and DOT1LY312A mutant HEK293T cells. We found that in DOT1LStop and DOT1LY312A 
mutants, H2AZ is depleted at the broken ends of DNA (Figure 5.17b). Our interpretation of this 
result is that histone remolding is defective in DOT1LStop and DOT1LY312A mutants and H2AZ 
cannot be efficiently removed and added back to the genome.  
We also analyzed H4 acetylation using BeL-ChIP because H4 acetylation has been 
shown to correlate with H2AZ exchange. There were no significant differences in H4 acetylation 
at DSB sites suggesting that our results in Figure 5.16b might represent a global deacetylation 
event and histones surrounding the break site can still be acetylated. If histones around the break 
site can still be acetylated it, could mean that at some level 53BP1 binding could be inhibited at 
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the break site [201]. This makes sense for the process of DSB repair to take place, as it is 
hypothesized that if 53BP1 is able to flank the DSB site, end resection will be blocked [202]. 
Perhaps H4 acetylation allows for some end resection to take place, allowing for the removal of 
histones around the DSB site.  
The consequence of H2AZ retention may be to restrict the end resection machinery [136]. 
In the absence of H2AZ, end resection is thought to be over-active and favor the generation of 
long ssDNA that is a poor substrate for HR and NHEJ [136]. In yeast, it has been observed that 
Dot1 mutants have a hyper-end resection phenotype, but this has not been reported in mammals 
[125]. We designed an assay to measure the length of ssDNA in a sequence independent manner 
(Chapter III for details). Briefly, we enriched for ssDNA following IR treatment, converted to 
dsDNA, ligated adaptors, and amplified the products. We observed an abundance of ssDNA 
fragments between 0.5kb to 3kb in DOT1LStop and DOT1LY312A mutants (Figure 5.18). This 
indicates that in the absence of DOT1L, cells generate more ssDNA. DOT1LStop and DOT1LY312A 
display different lengths of ssDNA generation with DOT1LStop generating abundant, but smaller 
ssDNA fragments while DOT1LY312A generates longer fragments. In both mutants, generation of 
ssDNA is a poor substrate for HR and could be why both DOT1LStop and DOT1LY312A have 
defects in HR. The differing effects both DOT1LStop and DOT1LY312A have on NHEJ and alt-
NHEJ could be explained in that DOT1LY312A have longer ssDNA fragments overall that block 
NHEJ, but not alt-NHEJ. DOT1LStop have shorter ssDNA fragments that can still be processed by 
NHEJ machinery, but are better substrates for alt-NHEJ. This points to a continuum of ssDNA 
generation and DNA repair pathway choice in DOT1L mutants.  
Discussion 
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 These results provide novel insights into the molecular function of Dot1L/DOT1L in 
DSB repair, and identify the importance of Dot1L in histone dynamics at the DSB sites. We 
identify a role for DOT1L and its methylation activity in promoting an open chromatin state that 
is permissive for H2AZ exchange, and allow HR DDR to take place. We propose the following 
model based on our observations and expand upon the model put forth by Brandon Price (Figure 
19.). . Under normal conditions DOT1L facilitates exchange of H2AZ at sites of DNA damage 
by marking histones with H3K79me. This transitions chromatin into a relax conformation by 
reducing the affinity of DNA to the core histone. In the absence of DOT1L and H3K79me H2AZ 
cannot be exchanged at sites of DNA damage efficiently do the higher affinity of DNA to the 
nucleosome. The reduction of H2AZ at DNA breaks leads to the generation of long ssDNA 
favors DNA repair pathways that are highly mutagenic and increase genomic instability. Our 
results have major implications in the use of DOT1L inhibitors as promising therapeutic for 
leukemia, and also identify other DNA repair pathways that are utilized in the absence of a 
functioning DOT1L. We predict that using DOT1L inhibitors in combination with inhibitors of 











Figure 5.1: Cells isolated from Dot1L-/- yolks sacs accumulate DNA damage. Cells from 
Dot1L+/+ and Dot1L-/- yolk sacs were cultured in erythroid differentiation media and then 











Figure 5.2: Cells isolated from Dot1L-/- embryos have altered cell cycle profiles and growth 
kinetics. A. The cycle profiles for Dot1L+/+ and Dot1L-/- cells isolated from E10.5 embryos were 
calculated using MANA (See Chapter IV). B. The growth kinetics of cells isolated from 



























Figure 5.3: Cells isolated from Dot1L-/- embryos have fewer cells that complete S and G2/M 
phases. BrdU assay on cells isolated from Dot1L+/+ and Dot1L-/- embryos. Cells were pulsed 
with BrdU for 24 hrs and BrdU incorporation was measured 24 and 96 hours after isolation from 












Figure 5.4: Cells isolated from Dot1L-/- embryos have high abnormal nuclei and 
micronuclei. A. Abnormally shaped nuclei were identified from the MANA output for both 
Dot1L+/+ and Dot1L-/- cells isolated from E10.5 embryos. B. Micronuclei abundance was 
calculated for Dot1L+/+ and Dot1L-/- cells isolated from E10.5 embryos. (Dot1L+/+ n=3, Dot1L-/- 
n=3, p-value < 0.01, two tailed t-test) 








Figure 5.5: Cells isolated from Dot1L-/- E10.5 embryos fail to repair induced DNA damage. 
Dot1L+/+ and Dot1L-/- cells were exposed to 2 Gy of ionizing radiation and measured for DNA 
damage levels using a alkaline comet assay 24, 72, and 96 hours post ionizing radiation 
treatment. (Dot1L+/+ n=3, Dot1L-/- n=3, p-value < 0.05, two tailed t-test) 











Figure 5.6: Cells isolated from Dot1L-/- E10.5 embryos continue to proliferate after ionizing 
radiation treatment. BrdU assay on cells isolated from Dot1L+/+ and Dot1L-/- embryos exposed 
to 2 Gy of ionizing radiation. Cells were pulsed with BrdU for 24 hrs and BrdU incorporation 
was measured 24 and 96 hours after isolation from embryos. (Dot1L+/+ n=3, Dot1L-/- n=3, p-









Figure 5.7: Cells isolated from Dot1L-/- E10.5 embryos have elevated expression of genes 
involved in DNA damage repair. qPCR was performed on RNA isolated from Dot1L+/+ and 
Dot1L-/- cells extracted from E10.5 embryos. A. DNA damage sensor genes. B. Homologous 
recombination genes. C. Non homologous end joining and alter non homologous end joining 









Figure 5.8: Cells isolated from Dot1L-/- E10.5 embryos have normal γH2AX foci formation. 
Dot1L+/+ and Dot1L-/- cells were exposed to 10 Gy of ionizing radiation and γH2AX foci was 
quantified 2 hours later. (Dot1L+/+ n=3, Dot1L-/- n=3, >100 cells per n, p value < 0.05, two tailed 
t-test). 







Figure 5.9: Cells isolated from Dot1L-/- E10.5 embryos have normal RAD51 foci formation. 
Dot1L+/+ and Dot1L-/- cells were exposed to 10 Gy of ionizing radiation and RAD51 foci was 









Figure 5.10: Cells isolated from Dot1L-/- E10.5 embryos have normal 53BP1 foci formation. 
Dot1L+/+ and Dot1L-/- cells were exposed to 10 Gy of ionizing radiation and 53BP1 foci was 
quantified 2 hours later. (Dot1L+/+ n=3, Dot1L-/- n=3, > 100 cells per n, p value < 0.05, two tailed 
t-test). 










Figure 5.11: Generation of HEK293T DOT1L nonsense and methyltransferase mutants. A. 
Diagram of Cas9 targeting scheme. eGFP-P2A-Cas9 and a 150nt ssODN are transfected into 
HEK293T cells and subjected to FACS. Negative eGFP clones were isolated and screened. B. 










Figure 5.12: Targeting schematic to generate the DOT1LSTOP HEK293T cell line. Human 
DOT1L locus shows the Cas9 target sequence and PAM site. Red nucleotides show the residues 
that are targeted for mutation with 150nt ssODN. Green shows the location of the DdeI site that 
is added. The gel demonstrates the PCR/resection enzyme (DdeI) screening. Bottom is a 










Figure 5.13: Targeting schematic to generate the DOT1LY312A HEK293T cell line. Human 
DOT1L locus shows the Cas9 target sequence and PAM site. Red nucleotides show the residues 
that are targeted for mutation with 150nt ssODN. Green shows the location of the DdeI site that 
is added. The gel demonstrates the PCR/resection enzyme (DdeI) screening. Bottom is a 

























Figure 5.14: DOT1LSTOPand DOT1LY312A mutants have altered kinetics in 53BP1 and 
BRCA1 foci formation and 53BP1/BRCA1 co localization. DNA damage foci were quantified 
in non IR treated cells and at 30, 60,90, 180, 360, 720 minutes post IR treatment. A. 53BP1 foci, 
B. BRCA foci, C. Co-localization of 53BP1/BRCA1 foci whose centroid is within 2 pixel units 
of each other. ** mark time points with p value < 0.05, pair t-test (wt vs Stop, wt vs Y312a).  











Figure 5.15: DOT1LSTOPand DOT1LY312A mutants have defects in severe defects in HR 
repair. A. DR-GFP assay was used to monitor HR repair activity in wild-type and DOT1LSTOP 
and DOT1LY312A mutants. B. E5J-GFP assay was used to monitor NHEJ repair activity in wild-
type and DOT1LSTOP and DOT1LY312A mutants. C. E2J-GFP assay was used to monitor HR repair 
activity in wild-type and DOT1LSTOP and DOT1LY312A mutants. GFP values were normalized to 
wild-type samples. (A. DOT1LWT n=3, DOT1LSTOPn=3, DOT1LY312A n=3, B. DOT1LWT n=3, 
DOT1LSTOPn=3, DOT1LY312A n=3,p C. DOT1LWT n=3, DOT1LSTOPn=3, DOT1LY312A n=3value < 












Figure 5.16: The stability of H2AZ is altered in DOT1LSTOPand DOT1LY312A mutants. A. 
H2AZ histone stability is increased in DOT1LSTOPand DOT1LY312A mutants following treatment 
with 10 Gy of ionizing radiation. B. H4K acetylation on DOT1LSTOPand DOT1LY312A mutant 
histones is reduced. C. H3 histone stability is increased in DOT1LSTOPand DOT1LY312A mutants. 












Figure 5.17: H2AZ is lost at the sites of DNA damage. A. Diagram of BeL-Chip assay. Broken 
end linker (Red) is ligated to the broken end. The genomic DNA is fragmented and crosslinked 
complexes are immunoprecipitated. A anchor linker (green) is ligated and DNA fragments are 
purified for analysis. B. qPCR of BeL-ChIP using H2AZ on wildtype, DOT1LSTOPand 
DOT1LY312A mutants 60 minutes post ionizing radiation (10Gy) treatment. C. qPCR BeL-ChIP 
using H4K acetylation on wildtype, DOT1LSTOPand DOT1LY312A mutants 60 minutes post 










Figure 5.18: DOT1LSTOPand DOT1LY312A mutants have altered single stranded DNA 
kinetics after DNA damage. Wildtype, DOT1LSTOPand DOT1LY312A mutants were exposed to 10 
Gy of ionizing radiation and ssDNA was isolated at 60 minutes and 240 minutes post ionization 
radiation. Asterisks mark major species of ssDNA.  












Figure 5.19: Model for DOT1L role in H2AZ exchange at sites of DNA damage. Under 
normal conditions DOT1L facilitates exchange of H2AZ at sites of DNA damage. In the absence 
of DOT1L H2AZ cannot be exchanged at sites of DNA damage. Our data indicate that H2AZ is 
more stable in the genome following ionizing radiation treatment in DOT1L mutants. This leads 
us to hypothesize that a lack of H3K79me compacts the chromatin reducing the efficiency of 
H2AZ exchange. Figure is adopted from the model put forth in [144].  
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Chapter VI: Concluding remarks and future perspectives. 
DNA Damage repair and disease  
 
   The fidelity of DNA damage repair pathways is essential for maintaining genome 
integrity. The loss of DNA repair fidelity will lead to the accumulation of unrepaired DNA 
lesions that can either lead to cellular death or disease. Spontaneous DNA lesions that escape the 
DNA repair machinery can be the source of spontaneous cancers and disorders that have no 
known etiology. However, a significant amount of human maladies is caused by known genetic 
mutations that alter DNA repair pathway genes. The following section contains examples of 
DNA repair pathway components and diseases associated with their defects. 
Diseases associated with BER 
 
     Components of the base excision repair pathway (BER) have been implicated in 
development of carcinomas and neurological diseases. It was found that OGG1 was directly 
involved in tumorigenesis in animal models. OGG1 mutations predisposed mice for the 
development of lung and ovarian tumors, and lymphomas [203]. In humans, missense mutations 
associated with OGG1 have been linked to kidney carcinomas [204]. The genetic cytology of 
Huntington disorder, a neurological diseases, is marked by the expansion of CAG nucleotides 
which is mediated by the age related hyper activity of OGG1[205].  
 OGG1 activity is partially dependent on the removal of histone 1 (H1) by nucleosome 
assembly protein 1 (NAP1) [17]. In the case of Huntington disorder, it is conceivable that drugs 
targeting the epigenetic pathways that facilitate H1 removal could work to slow the progression 
of the disease by limiting activity of OGG1. 
Diseases associated with MMR 
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Components of the mismatch repair pathway (MMR) have been implicated in development of 
various carcinoma including colon cancer and leukemias. The loss of functioning mismatch 
repair can be a result of mutations that silence the MMR genes or point mutations that alter the 
function of MMR genes. In humans, mutations that occur in the MSH2 gene are associated with 
Lynch syndrome, a subtype of colorectal cancer [206]. Mutations of the MSH2 and MLH1 have 
also been linked to cases of T-cell leukemia [207]. 
Diseases with nucleotide excision repair factors 
 
Nucleotide excision repair (NER) removes diverse DNA lesions, such as after UV-induced 
damage, bulky chemical adducts, or oxidative damage. Loss of NER proteins results in rare 
recessive syndromes: xeroderma pigmentosum, Cockayne syndrome, and a photosensitive 
disorder involving brittle hair disorder trichothiodystrophy [208]. Mutations in the XP genes 
(XPA,B,C) can cause xeroderma pigmentosum, which is a UV sensitivity that is associated with 
a more than 1000-fold increased risk of skin carcinoma, stressing the importance of these factors 
in the repair of UV damage.  
Diseases with ICL repair factors 
 
Defects in the repair components of the interstrand crosslinking repair (ICL) pathway predispose 
humans to a group of heterogeneous disorders that result from genomic instability: 
developmental abnormalities of major organ systems, bone marrow failure, and a high 
predisposition to cancer. Cellularly, there is a hypersensitivity to DNA crosslinking agents. 
Genes commonly associated with these disorders occur in the Fanconi anemia genes: FANCA, 






Diseases with SSB repair factors 
  
Single strand break (SSB) repair defects can cause neurological disorders and are also associated 
with cancers. Mutations in XRCC1 can lead to a neurological disorder known as ataxia-
oculomotor apraxia1 (AOA1), which is a type of spinocerebellar ataxia syndrome that includes 
symptoms such as cognitive impairment, hypercholesterolaemia, and involuntary movements [9]. 
The neurological manifestation of disease phenotypes associated with SSB repair suggests that 
the accumulation of SSB, which are the most common lesions in cells, result in progressive 
neurological dysfunction. Whether defects in SSB repair are associated with neurological 
degeneration involved in aging remains unknown.  
Diseases with DSB repair factors 
 
Double strand break (DSB) repair is central to the maintenance of genomic integrity, therefore it 
is not surprising that defects in genes central to HR and NHEJ result in cancers and Fanconi 
anemia. For example, mutations in BRCA1 and BRCA2 predispose women to breast and ovarian 
cancers [210]. Another example of DSB repair defects occurs in LIG4, the ligase necessary for 
repair during NHEJ. Hypomorphic mutations of LIG4 result in a syndrome characterized by 
microcephaly, immunodeficiency, and developmental retardation [211]. Many mutations of DSB 
repair machinery occur as hypomorphic mutations, suggesting that complete loss of the repair 
factor would be incompatible with viability.  
DOT1L inhibitors for the treatment of leukemia 
 
In the United States there are approximately 13 million individuals are currently living 
with cancer [212]. There are an estimated 1.6 million new cancer diagnoses each year with 
approximately 500,000 cancer-related deaths annually. Leukemia, a cancer of the blood, is the 
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most commonly diagnosed cancer in people aged 20 years and younger, representing 
approximately 26 percent of all cancer diagnoses in adolescents [212]. 
  A subtype of leukemia termed AML is linked with the lowest survival rates and the 
leading cause of leukemic deaths. AML patients undergo bone marrow failure due to a loss of 
hematopoietic progenitors, which decreases the production of neutrophils, platelets, and 
erythrocytes [213]. AML is characterized by the numerous cytogenetic chromosomal 
translocations: -5, -7, del(5q), t(6:9), t(9:22), abn17p, abn3q, and abn11q23 [164]. AML with the 
abn11q23 translocation has been termed Mixed Lineage Leukemia (MLL) and has proven to be 
one of the most treatment-resistant forms of leukemia. Initial genetic characterization of MLL 
identified a chromosomal break point at 11q23 causing the lysine methyltransferase 2 (MLL) to 
fuse with the gene MLLT1, super elongation complex subunit (ENL), which encodes a 
transcription elongation factor [166, 167]. Currently, over 100 translocation events have been 
identified in MLL patients, generating over 60 MLL fusion proteins, the most common being 
AF4/FMR2 family member 1 (AF4), MLLT3, super elongation complex subunit (AF9), ENL, 
myeloid/lymphoid or mixed-lineage leukemia; translocated to, 10 (AF10), afadin, adherens 
junction formation factor (AF6), elongation factor for RNA polymerase II (ELL), epidermal 
growth factor receptor pathway substrate 15 (AF1P), septin 6 (SEPT6), and MLLT6, PHD finger 
domain containing (AF17) [165]. Of those, AF9, AF10, ENL, AF17 partner with the H3K79 
methyltransferase disruptor of telomeric silencing 1-Like (DOT1L), and are part of the DotCom 
complex, which is involved in transcriptional activation in eukaryotes [108]. 
  A common strategy for drug discovery and anti-hematological cancer therapies is the 
targeting of epigenetic factors [214]; however, the molecular function of epigenetic regulators 
must be thoroughly examined in order to improve fficacy. In vitro experiments using cell lines 
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with MLL translocations have demonstrated that inhibition of DOT1L methylation can reduce 
cell viability [215].  We provide evidence here that the cytotoxic effects observed after inhibiting 
DOT1L activity could be a consequence of its role in DNA repair.  Further work is needed in 
order to gain a detailed understanding of the cellular functions of DOT1L as to improve the 
efficacy of DOT1L inhibitors.   
Final thoughts and future directions 
 
Anti-cancer therapies that exploit DNA repair pathway defects can work to further destabilize 
the genomes of cancerous cells driving them towards apoptosis. A fundamental understanding of 
the molecular and cellular functions of DNA repair factors will allow for more specified and 
improved targeted therapies. In order for these types of molecular therapies to come to fruition, 
an understanding of the molecular mechanism of DNA repair has to extend beyond cursory 
observations of end point repair assays. Better methodologies are necessary to gain deeper 
insights into dynamic processes of DNA repair. Thus, we developed novel and cutting edge 
methodologies and technologies to study mechanisms of DNA repair. We have applied those 
methodologies to identify the molecular functions of DOT1L in regulating DNA repair. We 
envision that the methodologies and technologies developed here can be can be applied to 
biological processes other than DNA repair factors (i.e. quantification of germ cells in the ovary 
or neuronal circuit mapping). 
     In this dissertation we identified the molecular mechanism of the role of DOT1L in DNA 
double strand break repair. We found that DOT1L regulates histone exchange at sites of DNA 
double strand breaks. DOT1L is primarily studied as a transcription regulator; however, we 
found that DOT1L and H3K79 methylation promote the exchange of H2AZ at DSB sites. The 
exchange of H2AZ into the nucleosome at DSB sites limits the amount of ssDNA generated, 
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which, if left unchecked, would result in the utilization of highly mutagenic repair pathways. 
These findings have defined the molecular mechanism for how DOT1L facilitates DNA damage 
repair and provide insights into how the epigenetic code can direct DNA repair pathway 
utilization. 
     In future studies, it will be interesting to examine if other epigenetic factors regulate 
DNA damage in a similar fashion as DOT1L in double strand break repair, and if the function of 
DOT1L in DSB repair can be extended to other types of DNA damage repair. DNA damage 
pathway utilization is influenced by the epigenetic state of the DNA where the damage takes 
place. Examination of the epigenetic state during different types of DNA repair might reveal 
precise mechanisms of regulation necessary for damage detection and repair. This information 
could be used for the development and application of novel molecular therapeutics to treat 
diseases states or for therapeutic interventions designed to limit the effects of genotoxic 
environmental factors. 
     To test our central hypothesis, we developed methodologies and technologies that 
facilitated in elucidating the molecular mechanism of DOT1L action during DSB DNA repair. 
The development of BEL-ChIP allows for precise temporal interrogation of nucleosome 
composition and modifications at sites of DNA damage on a genome wide scale. The 
nucleosome composition and modification state can influence end resection at DSB sites, which 
in turn can influence the type of DNA repair pathway used. Next, we developed a method to 
measure genome wide end resection events at nucleotide resolution using Oxford Nanopore 
technology. Using this method it is now possible capture all single stranded regions generated 
after DSB formation. Finally, we developed image analysis software called MANA. MANA can 
autonomously quantify the spatial and temporal formation of nuclear foci events as well as cell 
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cycle staging using deep learning neural networks. The usefulness of these technologies and 
methodologies extend beyond their application in the interrogation of the function of DOT1L in 
DNA repair and can be applied to interrogation of all epigenetic factors during DNA repair. 
     Understanding the role of DOT1L during DNA double strand break repair provides 
greater understanding of how DNA repair is regulated and expands our understanding of how 
epigenetics can regulate processes beyond transcriptional control. The identification of DOT1L 
function in DNA repair provides new opportunities for design and implementation of molecular 
therapeutics strategies that target DNA repair pathways to treat diseases.  
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